Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.3165428342277803e-34,30.891138637446403,2409.9068128628924,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS6KB1', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.820264435313015e-32,0,0,81
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.391723197927423e-15,5.638074460516955,182.73862238568591,"['COX7B', 'NDUFA12', 'COX4I1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'COX7A2L', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'NDUFS3', 'NDUFS1', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'SLC25A27', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1E', 'UQCRQ', 'ATP5PO']",2.4923417897844443e-12,0,0,62
3,Oxidative phosphorylation WP623,9.879849938835264e-10,5.979760220920051,123.99244266389445,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'NDUFS3', 'ATP5PO', 'NDUFS1']",1.956210287889382e-07,0,0,37
4,Nonalcoholic fatty liver disease WP4396,5.4451400586152425e-09,2.828384530718431,53.82003484880356,"['GSK3B', 'NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'PIK3CB', 'COX7C', 'BBC3', 'AKT3', 'LEPR', 'MLX', 'UQCRFS1', 'RAC1', 'MAP3K5', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'COX7A2L', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS4', 'NDUFS3', 'NDUFS1', 'PPARA', 'ATF4', 'NDUFB9', 'PRKAA1', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'PIK3R3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'COX7A1', 'UQCRH', 'CDC42', 'MAPK8', 'CYC1', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'INSR', 'NDUFA3', 'NDUFA1', 'COX6C', 'NFKB1', 'MLXIPL', 'ITCH', 'UQCRQ', 'CYCS', 'BAX']",8.086032987043636e-07,0,0,71
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.2912918706847867e-06,4.016011302095597,54.45658069542299,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NUBPL', 'NDUFA3', 'ACAD9', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'NDUFS3', 'NDUFAF3', 'NDUFS1', 'TMEM126B']",0.00015340547423735266,0,0,32
6,Mitochondrial CIV Assembly WP4922,2.048109331782729e-06,5.766212406015038,75.52927215394811,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'COX4I1', 'COX17', 'CMC1', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX11', 'COX14', 'COX10', 'COX20']",0.00020276282384649018,0,0,23
7,Photodynamic therapy-induced unfolded protein response WP3613,0.00031420272080470073,4.505747126436781,36.34097806555611,"['XBP1', 'WARS', 'HSPA5', 'UBE2E1', 'PDIA6', 'HSP90B1', 'BBC3', 'NARS', 'DDIT3', 'DNAJB11', 'DNAJB9', 'TRIB3', 'CALR', 'ATF6', 'EIF2A', 'ATF4']",0.026662345165427464,0,0,16
8,Cellular Proteostasis WP4918,0.0008522917155322541,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.06328265987826986,0,0,6
9,Regulation of Microtubule Cytoskeleton WP2038,0.0012437138625312077,2.7545219638242893,18.426797014536834,"['GSK3B', 'TRIO', 'ROCK1', 'PRKCA', 'CDC42', 'TIAM1', 'CLIP1', 'APC', 'PIK3CA', 'CFL2', 'DPYSL2', 'TAOK1', 'CAMK4', 'GNAQ', 'STMN1', 'ABL1', 'TPPP', 'RAC1', 'PRKACA', 'CLASP1', 'MARK2', 'MARK1']",0.08208511492705971,0,0,22
10,Fragile X Syndrome  WP4549,0.0014614888236488233,1.7995653973509933,11.748102100808406,"['CYFIP2', 'CYFIP1', 'ABCD3', 'CLTC', 'CLTA', 'PIK3CB', 'SLC6A1', 'GRM1', 'RPTOR', 'GRIP1', 'PPP3CA', 'GRM5', 'PRKACA', 'AP2M1', 'PDK1', 'EPHA4', 'DUSP3', 'KCND2', 'GAB1', 'PPP2R5B', 'PRKCA', 'DICER1', 'DNM2', 'EEF1A1', 'CREB1', 'ALDH5A1', 'PRKAR1A', 'SOS1', 'PLCB1', 'TELO2', 'GRIA2', 'ITPR1', 'AKAP5', 'GRIN2A', 'MKNK1', 'AP2S1', 'MAPK1', 'FYN', 'NTRK2', 'GAD1', 'BRAF', 'AP2B1', 'GRIN2B', 'TARBP2', 'ARHGAP32', 'RPS6KB1', 'CAMK4', 'NF1', 'PTPN5', 'EIF4G1', 'HCN1']",0.0868124361247401,0,0,51
11,Methionine De Novo and Salvage Pathway WP3580,0.0019811671310643163,4.952061855670103,30.821975413901153,"['MSRA', 'AHCY', 'ADI1', 'CHDH', 'ODC1', 'MSRB2', 'SMS', 'MSRB3', 'TXN', 'MAT2B', 'SRM']",0.10698302507747308,0,0,11
12,Androgen receptor signaling pathway WP138,0.004337870642746789,1.8543611504007544,10.088413899338839,"['RB1', 'GSK3B', 'ROCK1', 'ROCK2', 'HDAC1', 'RNF4', 'NR2C2', 'FOXO1', 'EGFR', 'CDC42', 'CCND1', 'SUMO1', 'KAT5', 'BAG1', 'RACK1', 'EP300', 'RAC1', 'PATZ1', 'NCOA1', 'NCOA2', 'CREBBP', 'NCOA3', 'DSTN', 'PIAS2', 'RUNX2', 'PTK2', 'PIAS1', 'RHOB', 'KAT2B', 'CREB1', 'NCOR1', 'ZNF318', 'CALR', 'FKBP4', 'PLPP1', 'RAN', 'RAD9A']",0.2059933653293684,0,0,37
13,Mitochondrial complex III assembly WP4921,0.004508272305188197,4.5008198641368,24.312714534818866,"['UQCRB', 'UQCC3', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.2059933653293684,0,0,10
14,Pyrimidine metabolism WP4022,0.009081109235988562,1.7823759826882515,8.379945720300437,"['PRIM2', 'DTYMK', 'POLD4', 'ZNRD1', 'POLR2C', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'ENPP3', 'POLR2I', 'POLR2K', 'POLR2L', 'PNPT1', 'POLR3GL', 'NME2', 'CTPS1', 'NME4', 'NME1', 'DHODH', 'POLE4', 'POLA1', 'POLR3A', 'RRM2B', 'NME7', 'POLR1C', 'DPYD', 'POLE3', 'POLR1E', 'CMPK2', 'DCTPP1', 'POLR3K']",0.36880776750257627,0,0,34
15,Rett syndrome causing genes WP4312,0.009476737241344364,2.0723778195488722,9.655032512883968,"['KDM5B', 'MEF2C', 'EIF2B2', 'CDKL5', 'KCNJ10', 'TRRAP', 'HDAC1', 'SATB2', 'STXBP1', 'BRAF', 'SMARCA1', 'GRIN2B', 'XAB2', 'GRIN2A', 'NCOR1', 'TBL1XR1', 'SCN8A', 'IMPDH2', 'TCF4', 'HIVEP2', 'HAP1', 'SCN2A', 'SCN1A']",0.36880776750257627,0,0,23
16,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.009934215959665354,2.1498569537554975,9.914646498210518,"['PPP1R16B', 'PPP1R14A', 'XBP1', 'PPP1R13B', 'PPP1R12A', 'PPP1R11', 'HSPA5', 'EIF2AK2', 'PPP1R9A', 'PPP1CC', 'PPP1R2', 'PPP1R3F', 'MAPK8', 'MAP1LC3A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'PPP1R12B', 'ATF6', 'ATF4']",0.36880776750257627,0,0,21
17,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.01297208578693857,3.0940721649484537,13.443605800315387,"['EGLN1', 'PRKAA1', 'LDHA', 'PDHA1', 'RPS6', 'PRKAG1', 'KEAP1', 'PDHB', 'ACACB', 'ACACA', 'PDK1']",0.4481901965424122,0,0,11
18,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.013581521107345824,2.0561704821614555,8.839569743585358,"['EIF4A2', 'MAP2K3', 'MAP2K4', 'RPS6', 'PIK3R3', 'PRKCA', 'PIK3CB', 'RPTOR', 'MAPK10', 'MAPK8', 'RPS6KB1', 'PIK3CA', 'RPS6KA2', 'AKT3', 'MAPK1', 'PIM2', 'PRKACA', 'EIF4G3', 'EIF4B', 'PDK1', 'EIF4G1']",0.4481901965424122,0,0,21
19,Glycolysis and Gluconeogenesis WP534,0.014941364131818277,2.411719378182793,10.137956144194126,"['PDHA1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A3', 'ENO2', 'GCK', 'LDHA', 'PKM', 'PC', 'PGK1', 'ALDOC', 'ALDOA', 'PFKM', 'PFKP']",0.46711422601579244,0,0,15
20,Proximal tubule transport WP4917,0.017191568891451493,2.132857372250151,8.666516561719089,"['ATP6V1A', 'ATP6V1G1', 'SLC22A6', 'ABCB1', 'SLC20A2', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'SLC4A2', 'ATP1A1', 'ATP1B1', 'SLC4A4', 'FXYD2', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.5105895960761093,0,0,18
21,Synaptic Vesicle Pathway WP2267,0.020096703527046445,1.9053866030610216,7.444725546578094,"['UNC13C', 'RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTC', 'CACNA1B', 'CLTA', 'SYP', 'AP2B1', 'SYN3', 'CPLX2', 'SYN2', 'DNM2', 'CPLX3', 'DNM3', 'RIMS1', 'AP2S1', 'SLC17A7', 'STX2', 'SLC25A4', 'AP2M1']",0.5684496140507422,0,0,22
22,Endoderm differentiation WP2853,0.021102998326141972,1.525994005994006,5.887803938675296,"['CTR9', 'WNT8A', 'RTF1', 'LAMC1', 'NR3C1', 'FOXO1', 'ACACA', 'CDC73', 'SOX2', 'MBTD1', 'CAND1', 'SESN1', 'TCEAL2', 'UBR5', 'LEO1', 'ASCC3', 'JARID2', 'BPTF', 'MAP2K3', 'SMAD2', 'VAV3', 'TGFB1', 'STAT1', 'PBX3', 'CDYL', 'TRERF1', 'EMSY', 'PIAS1', 'NME1', 'EXT1', 'TNRC6C', 'TOX3', 'SFRP1', 'DDAH1', 'APC', 'RFX7', 'SP4', 'NABP2', 'TCF4', 'CEBPZ', 'WDFY2', 'NAA15', 'TOX', 'BMPR1A']",0.5697809548058332,0,0,44
23,IL-6 signaling pathway WP364,0.023442740978807778,2.026003285613706,7.603984155868588,"['NCOA1', 'GSK3B', 'MAP2K4', 'CREBBP', 'HDAC1', 'STAT1', 'GAB1', 'NR2F6', 'HCK', 'RPS6KB1', 'IRF1', 'MAPK1', 'RAC1', 'JAK2', 'SOS1', 'VIP', 'IL6ST', 'MAP3K7']",0.6054342670179053,0,0,18
24,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.026001418187957943,2.2504103165298943,8.213106935633936,"['ATF1', 'CAMK2D', 'CAMK1D', 'ITPR1', 'ITPR2', 'CREB3', 'CREB1', 'STAR', 'CAMK4', 'GNAQ', 'CALM3', 'CALM1', 'CAMK1G', 'ATF4']",0.643535100151959,0,0,14
25,Nanomaterial-induced inflammasome activation WP3890,0.029215478051768974,inf,inf,"['TLR4', 'NFKB1', 'CTSB']",0.6940156157103301,0,0,3
26,Pregnane X receptor pathway WP2876,0.030377787893044753,2.8921043827367012,10.10513880627437,"['NCOA1', 'NCOA2', 'HSP90AA1', 'PSMC5', 'ABCB1', 'NCOA3', 'CYP3A5', 'PPARGC1A', 'FOXO1']",0.6940156157103301,0,0,9
27,PKC-gamma calcium signaling pathway in ataxia WP4760,0.03190126666012207,2.474742268041237,8.525758253009569,"['GRIA2', 'PLCB4', 'GNAQ', 'ITPR1', 'ATP2B2', 'CA8', 'PLCB1', 'GRM1', 'GRIA3', 'PDK1', 'GRIA4']",0.7018278665226856,0,0,11
28,EGF/EGFR signaling pathway WP437,0.03531309005773804,1.3818630522149722,4.620261271637546,"['ATF1', 'NDUFA13', 'SH3KBP1', 'PEBP1', 'CBLB', 'RPS6KA2', 'STMN1', 'NCK2', 'PLCE1', 'RAC1', 'JAK2', 'HRAS', 'MAP3K4', 'SH3GL2', 'AP2M1', 'MEF2A', 'VAV3', 'USP8', 'RALBP1', 'MEF2C', 'NCOA3', 'GAB1', 'PRKCA', 'GAB2', 'EPN1', 'CREB1', 'RASA1', 'SOS1', 'STAM2', 'SOS2', 'ARF6', 'ROCK1', 'STXBP1', 'NEDD8', 'ASAP1', 'CBL', 'FOXO1', 'EGFR', 'CDC42', 'ATXN2', 'MAPK8', 'RAP1A', 'ABL1', 'AP2S1', 'MAPK1', 'RICTOR', 'MEF2D', 'STAT5B', 'MAP3K1', 'STAT1', 'BRAF', 'PTPN12', 'AP2B1', 'PTK2', 'ITCH', 'RPS6KB1', 'PTPN5']",0.7198566699921711,0,0,57
29,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.036665743231641304,2.998829313977991,9.91386697487853,"['CD63', 'CD81', 'SPP1', 'SORBS2', 'PDLIM5', 'TLR4', 'EGFR', 'SOD1']",0.7198566699921711,0,0,8
30,Energy Metabolism WP1541,0.036976059722931026,1.800798309462315,5.938104711653046,"['NCOA1', 'MEF2A', 'GSK3B', 'PRKAA1', 'MEF2C', 'HDAC1', 'PRKAG1', 'NRF1', 'FOXO1', 'PPP3CA', 'PPP3CC', 'PPP3R2', 'CREB1', 'CAMK4', 'EP300', 'TFAM', 'PPARG', 'PPARA', 'PPARGC1A', 'MEF2D']",0.7198566699921711,0,0,20
31,Myometrial relaxation and contraction pathways WP289,0.04190876986431316,1.4048442694152927,4.4565315199603,"['ATF1', 'RYR1', 'RYR2', 'CAMK2D', 'RGS14', 'YWHAB', 'RGS16', 'LPAR1', 'ITPR1', 'ITPR2', 'ATP2A2', 'ADCY8', 'SLC8A1', 'ACTG1', 'ADCY5', 'RGS4', 'RGS2', 'GNG3', 'GRK5', 'YWHAQ', 'PRKAR2B', 'GNG4', 'PRKAR2A', 'PRKACA', 'RGS9', 'RGS7', 'GUCY1A1', 'GSTO1', 'IGFBP3', 'PRKCE', 'PDE4D', 'PRKCA', 'NFKB1', 'PKIB', 'CREB3', 'ADCY9', 'CREB1', 'PRKAR1A', 'GNAQ', 'MAFF', 'GNB1', 'CRH', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'ATF4']",0.7198566699921711,0,0,48
32,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.04427949794264539,3.148361423220974,9.814177728317668,"['RYR1', 'RYR2', 'TRPC1', 'GNAQ', 'ITPR1', 'CCK', 'PLCB1']",0.7198566699921711,0,0,7
33,Exercise-induced Circadian Regulation WP410,0.04697009626500102,1.731356223020933,5.294910005032929,"['NCKAP1', 'IDI1', 'DAZAP2', 'HSPA8', 'BTG1', 'ZFR', 'QKI', 'AZIN1', 'ETV6', 'DNAJA1', 'PPP2CB', 'SUMO1', 'STBD1', 'KLF9', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'CLOCK', 'EIF4G2']",0.7198566699921711,0,0,20
34,Constitutive Androstane Receptor Pathway WP2875,0.047244455256165295,2.530327868852459,7.723623345377004,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'ABCB1', 'NCOA6', 'CYP3A5', 'PPARGC1A', 'FOXO1']",0.7198566699921711,0,0,9
35,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.047244455256165295,2.530327868852459,7.723623345377004,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF3D', 'EIF1']",0.7198566699921711,0,0,9
36,Calcium Regulation in the Cardiac Cell WP536,0.04798405193566715,1.3866879988364271,4.211214166856097,"['RYR1', 'RYR2', 'CAMK2D', 'CHRM1', 'RGS14', 'YWHAB', 'RGS16', 'CACNA1B', 'ITPR1', 'GNAI3', 'ITPR2', 'ATP2A2', 'CACNA1C', 'ADCY8', 'SLC8A1', 'ADCY5', 'RGS4', 'RGS2', 'GNG3', 'GJC2', 'GRK5', 'YWHAQ', 'PRKAR2B', 'GNG4', 'PRKAR2A', 'ANXA6', 'PRKACA', 'RGS9', 'RGS7', 'KCNJ3', 'PRKCE', 'ATP2B3', 'PRKCA', 'ATP2B2', 'ATP1B2', 'ATP1B1', 'PKIB', 'ADCY9', 'PRKAR1A', 'FXYD2', 'GNAQ', 'CAMK4', 'GNB1', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1']",0.7198566699921711,0,0,48
37,VEGFA-VEGFR2 Signaling Pathway WP3888,0.053179149299810914,1.2024072723851635,3.527969819057147,"['RPL5', 'TRAF3IP2', 'FHOD1', 'RPL10A', 'SLC8A1', 'RPL7', 'ACTG1', 'RPL18A', 'CCND1', 'ATP6V1E1', 'MAP3K5', 'EIF2A', 'MAP2K3', 'TMOD1', 'MAP2K4', 'MEF2C', 'TPM3', 'FBXW11', 'PRKCE', 'IGFBP3', 'RPS6', 'SARS', 'ADAM10', 'PRKCA', 'PDIA6', 'SND1', 'EWSR1', 'KATNAL2', 'FSCN1', 'TFAM', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'ATF6', 'VCL', 'ATF4', 'SET', 'EPB41', 'PXN', 'HTRA1', 'TXN', 'ACACB', 'FOXO1', 'ACACA', 'STIP1', 'LDHA', 'RAP1A', 'MYO6', 'PGK1', 'ABL1', 'FADD', 'TXNDC5', 'CREBBP', 'SDF2L1', 'PRRC2C', 'NFKB1', 'QKI', 'PTK2', 'AFDN', 'BMP2', 'SPIRE1', 'CYCS', 'HYOU1', 'CALR', 'GRSF1', 'EIF4G2', 'EIF4G1', 'ARF4', 'GSK3B', 'FAF1', 'CLTC', 'LDB2', 'PPP3CA', 'TMSB4X', 'RACK1', 'RPLP2', 'LRRFIP2', 'ELOC', 'RAC1', 'ACP1', 'HRAS', 'PRKG1', 'HSP90AA1', 'SSR4', 'TRPC1', 'SSR3', 'GAB1', 'ARNT', 'RPL13A', 'EPN1', 'RCN1', 'CREB1', 'PIK3CA', 'NUMB', 'TKT', 'ALDOA', 'PTMA', 'ENG', 'ARF6', 'PRKAA1', 'ROCK1', 'HDAC1', 'ROCK2', 'CBL', 'CDC42', 'MAPK8', 'MKNK1', 'FAM120A', 'AP2S1', 'DNAJB9', 'MAPK1', 'FLNB', 'RICTOR', 'FYN', 'ASCC3', 'CCT7', 'ABCF2', 'BRD4', 'RBM39', 'STAT1', 'PDE4DIP', 'RAB11A', 'DNAJA1', 'ITCH', 'RPS6KB1', 'PTPN9', 'P4HB', 'EIF3F', 'COPG1', 'EIF3D']",0.7198566699921711,0,0,131
38,Aryl Hydrocarbon Receptor Pathway WP2873,0.05334151224851213,2.0765445007301113,6.086435843794947,"['NCOA1', 'HSP90AA1', 'CDKN1B', 'TGFB1', 'PTGES3', 'CDC37', 'AIP', 'EP300', 'ARNT', 'BAX', 'AHR', 'EGFR']",0.7198566699921711,0,0,12
39,Leptin signaling pathway WP2034,0.053696758666711066,1.5375894337630744,4.496530598276609,"['GSK3B', 'PRKAA1', 'ROCK1', 'ROCK2', 'ACACB', 'FOXO1', 'ACACA', 'CDC42', 'SOCS2', 'MAPK8', 'CCND1', 'CFL2', 'LEPR', 'MAPK1', 'FYN', 'RAC1', 'JAK2', 'HRAS', 'NCOA1', 'STAT5B', 'STAT1', 'RPS6', 'PTK2', 'NFKB1', 'CREB1', 'RPS6KB1', 'BAX', 'SOS1']",0.7198566699921711,0,0,28
40,Disruption of postsynaptic signaling by CNV WP4875,0.05411595745863646,1.875,5.468674076916883,"['RYR2', 'CYFIP1', 'NLGN1', 'CAMK2D', 'NLGN4X', 'NRXN3', 'GRIN2B', 'GRM1', 'RPH3A', 'TJP1', 'GRIN2A', 'DLG1', 'DLG2', 'MAPK1', 'DLGAP1']",0.7198566699921711,0,0,15
41,p38 MAPK Signaling Pathway WP400,0.05411595745863646,1.875,5.468674076916883,"['MAP2K4', 'MAP3K1', 'STAT1', 'TRADD', 'CDC42', 'CREB1', 'MKNK1', 'DDIT3', 'MAP3K9', 'RAC1', 'HRAS', 'MEF2D', 'MAP3K7', 'HMGN1', 'MAP3K5']",0.7198566699921711,0,0,15
42,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.05662301556623223,2.249238697587257,6.458328459334608,"['GSK3B', 'PPP3CA', 'RASA1', 'DYRK1A', 'FYN', 'PRKCA', 'CALM1', 'RASGRP1', 'NFKB1', 'PDK1']",0.7198566699921711,0,0,10
43,Ras signaling WP4223,0.05707638786259284,1.3327452956989247,3.8161359276082827,"['PIK3CB', 'IGF1R', 'AKT3', 'PLCE1', 'RAC1', 'PRKACA', 'HRAS', 'RALBP1', 'KSR1', 'PLA2G4C', 'GAB1', 'PRKCA', 'KSR2', 'GAB2', 'TIAM1', 'MRAS', 'PIK3CA', 'RASA1', 'RASA2', 'SOS1', 'SOS2', 'EXOC2', 'ARF6', 'RAB5C', 'PIK3R3', 'RASAL2', 'RASGRP2', 'RASGRP1', 'EGFR', 'CDC42', 'GNG10', 'GRIN2A', 'GNG3', 'MAPK8', 'RAP1A', 'GNG4', 'ABL1', 'ABL2', 'MAPK1', 'SHOC2', 'PAK3', 'PAK5', 'NTRK2', 'INSR', 'GRIN2B', 'NFKB1', 'MAPK10', 'AFDN', 'GNB1', 'NF1', 'CALM3', 'GNB5', 'RGL1', 'CALM1', 'FGFR2']",0.7198566699921711,0,0,55
44,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.05777479059514942,2.5701575408903903,7.3280402416247945,"['TJP1', 'CREB1', 'PXN', 'ITPR1', 'MAPK1', 'LPP', 'PTK2', 'VCL']",0.7198566699921711,0,0,8
45,Chemokine signaling pathway WP3929,0.059099586120486235,1.3912729595024227,3.935259192978167,"['GSK3B', 'ROCK1', 'ROCK2', 'PXN', 'GNAI3', 'PIK3R3', 'PIK3CB', 'RASGRP2', 'ADCY8', 'CXCL14', 'CX3CL1', 'ADCY5', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'GRK5', 'GNG4', 'AKT3', 'MAPK1', 'RAC1', 'JAK2', 'HRAS', 'VAV3', 'STAT5B', 'STAT1', 'BRAF', 'PTK2', 'NFKB1', 'TIAM2', 'TIAM1', 'HCK', 'ADCY9', 'PLCB4', 'PIK3CA', 'GNB1', 'ELMO1', 'GNB5', 'SOS1', 'PLCB1', 'SOS2', 'NFKBIB']",0.7198566699921711,0,0,42
46,Selenium Micronutrient Network WP15,0.061530009260731815,1.6297355080092646,4.544077871812987,"['ABCA1', 'GPX4', 'TXNRD2', 'INSR', 'APOA1', 'TXN', 'KMO', 'SELENOK', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX4', 'SELENOS', 'FLAD1', 'SELENOP', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2', 'MSRB1']",0.7198566699921711,0,0,21
47,Common Pathways Underlying Drug Addiction WP2636,0.06252037322422278,1.7387270167654965,4.82020823448794,"['GRIA2', 'PRKCA', 'ADCY8', 'GRM1', 'ACTG1', 'PPP1CC', 'GRIN2A', 'GRM5', 'RAP1A', 'CREB1', 'CAMK4', 'MAPK1', 'DRD1', 'PRKACA', 'CALM1', 'GRIA3', 'GRIA4']",0.7198566699921711,0,0,17
48,Metabolic reprogramming in colon cancer WP4290,0.06252037322422278,1.7387270167654965,4.82020823448794,"['TIGAR', 'PDHA1', 'MDH2', 'PGAM1', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'GLS', 'RPIA', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'TKT', 'SLC16A3', 'PSPH']",0.7198566699921711,0,0,17
49,Joubert Syndrome WP4656,0.06395998379654945,1.500823335685721,4.126510226058902,"['MRE11', 'CETN2', 'ARL3', 'CEP120', 'KAT5', 'TCTN3', 'SUFU', 'CSPP1', 'TMEM67', 'MYO6', 'INPP5E', 'BBS9', 'NPHP4', 'CEP290', 'PIBF1', 'BBS4', 'ARMC9', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'NIN', 'TMEM17', 'KIAA0586', 'TMEM237', 'ATM', 'CEP41', 'ATF4']",0.7198566699921711,0,0,28
50,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.06439688827313993,3.747075339260646,10.277065934009167,"['TIFA', 'UBE2N', 'UBE2V1', 'SQSTM1', 'NFKB1']",0.7198566699921711,0,0,5
51,Leptin and adiponectin WP3934,0.06439688827313993,3.747075339260646,10.277065934009167,"['PRKAA1', 'PRKAG1', 'LEPR', 'ADIPOR1', 'ACACA']",0.7198566699921711,0,0,5
52,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.06439688827313993,3.747075339260646,10.277065934009167,"['MEF2A', 'CAMK2D', 'MEF2C', 'CCND2', 'MEF2D']",0.7198566699921711,0,0,5
53,Sleep regulation WP3591,0.06486363927670381,2.0618556701030926,5.640140350418509,"['CHRNB2', 'CACNA1I', 'NLGN1', 'GRIN2A', 'AHCY', 'PER3', 'STAR', 'ADORA2A', 'CRH', 'DRD1', 'BTBD9']",0.7198566699921711,0,0,11
54,Pathways in clear cell renal cell carcinoma WP4018,0.06544151545383374,1.483807486631016,4.045747162049893,"['SETD2', 'BHLHE41', 'PLOD2', 'ENO2', 'ACACB', 'ACACA', 'EGFR', 'RPTOR', 'LDHA', 'ME1', 'PGK1', 'EP300', 'ENPP3', 'CEP290', 'PSPH', 'KCNJ2', 'PBRM1', 'CREBBP', 'TGFB1', 'KSR1', 'ARNT', 'ACLY', 'PKM', 'ZEB1', 'ALDOC', 'ALDOA', 'SQSTM1', 'PFKM', 'PFKP']",0.7198566699921711,0,0,29
55,Pathways affected in adenoid cystic carcinoma WP3651,0.06856111559155124,1.5433808964243747,4.136306691868908,"['MAGI1', 'SETD2', 'CREBBP', 'FBXW7', 'CNTN6', 'KMT2C', 'MAGI2', 'ATRX', 'ERBIN', 'JMJD1C', 'ARID5B', 'ARID4B', 'DTX4', 'FOXP2', 'NCOR1', 'PIK3CA', 'NFIB', 'KAT6A', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'HRAS']",0.7404600483887535,0,0,24
56,Airway smooth muscle cell contraction WP4962,0.07095067851920894,2.623361423220974,6.940811771410024,"['RYR1', 'PPP1R14A', 'ROCK1', 'ROCK2', 'GNAQ', 'PLCB1', 'CALM1']",0.7525839828644664,0,0,7
57,G1 to S cell cycle control WP45,0.07518740156678541,1.5752465946453733,4.076378391827034,"['RB1', 'CDKN2D', 'PRIM2', 'CDKN1B', 'GADD45A', 'ORC5', 'CREB3', 'CCND2', 'CREB1', 'ORC6', 'CDK6', 'CCND1', 'CCNE2', 'TFDP2', 'RPA3', 'CCNG2', 'ORC2', 'MCM4', 'ATM', 'MCM6', 'MNAT1']",0.7622288443950012,0,0,21
58,Insulin signaling in adipocytes (diabetic condition) WP3635,0.07699281256515163,4.495906432748538,11.527698338282704,"['TBC1D4', 'RPS6KB1', 'INSR', 'RPS6']",0.7622288443950012,0,0,4
59,Insulin signaling in adipocytes (normal condition) WP3634,0.07699281256515163,4.495906432748538,11.527698338282704,"['TBC1D4', 'RPS6KB1', 'INSR', 'RPS6']",0.7622288443950012,0,0,4
60,miRNA Biogenesis WP2338,0.07699281256515163,4.495906432748538,11.527698338282704,"['DROSHA', 'DICER1', 'TARBP2', 'RAN']",0.7622288443950012,0,0,4
61,Circadian rhythm related genes WP3594,0.07992586789771432,1.2906901041666667,3.2611295411433554,"['GSK3B', 'CHRM1', 'BHLHE41', 'RORA', 'AHR', 'RORB', 'HEBP1', 'PPP1CC', 'DBP', 'EP300', 'BTRC', 'SKP1', 'CHRNB2', 'PRMT5', 'NCOA2', 'KCND2', 'FBXW11', 'KCNH7', 'USP2', 'DYRK1A', 'ARNT', 'NCOR1', 'CREB1', 'ADORA2A', 'PSPC1', 'CRY2', 'CRH', 'CRY1', 'PPARG', 'ATF5', 'PPARA', 'CLOCK', 'UBA52', 'ATF4', 'NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'ROCK2', 'HDAC1', 'MAPK8', 'UBC', 'DRD1', 'RPS27A', 'PPARGC1A', 'OPN3', 'NTRK3', 'BTBD9', 'NR2F6', 'MAPK10', 'PER3', 'STAR', 'GNAQ', 'KLF9', 'LGR4']",0.7762197826462078,0,0,55
62,ErbB signaling pathway WP673,0.08143238062131482,1.4017499266790499,3.5155639893578248,"['GSK3B', 'CAMK2D', 'CDKN1B', 'PIK3R3', 'CBLB', 'PIK3CB', 'CBL', 'FOXO1', 'EGFR', 'MAPK8', 'CCND1', 'ERBB4', 'AKT3', 'NCK2', 'ABL1', 'MAPK1', 'ABL2', 'PAK3', 'HRAS', 'PAK5', 'MAP2K4', 'STAT5B', 'GAB1', 'PRKCA', 'BRAF', 'NRG2', 'PTK2', 'MAPK10', 'NRG3', 'PIK3CA', 'RPS6KB1', 'SOS1', 'SOS2']",0.7762197826462078,0,0,33
63,7q11.23 copy number variation syndrome WP4932,0.0823263405836887,1.391746439661634,3.4752801637660347,"['RB1', 'TSG101', 'CLTC', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'CLDN1', 'ACACB', 'FBLN5', 'ACACA', 'ATP5MC1', 'GRIP1', 'ATP5F1A', 'ATP5F1B', 'NUP62', 'EIF4H', 'PRKG1', 'CLASP1', 'EIF2A', 'BRD4', 'ATP5PB', 'UBE2E1', 'VPS37C', 'HSPA2', 'ATP5F1E', 'CLIP2', 'MLXIPL', 'DNAJC30', 'ATP5PO', 'GTF2IRD1', 'SQSTM1', 'ATF4', 'FBN1']",0.7762197826462078,0,0,34
64,Glycolysis in senescence WP5049,0.08759445457016887,2.6979639597472502,6.569643650455949,"['RB1', 'LDHA', 'PRKAA1', 'PKM', 'PGK1', 'ALDOC']",0.7842069269468361,0,0,6
65,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.08759445457016887,2.6979639597472502,6.569643650455949,"['SFRP1', 'ZEB2', 'TGFB1', 'CCND1', 'NRG3', 'ERBB4']",0.7842069269468361,0,0,6
66,RalA downstream regulated genes WP2290,0.08759445457016887,2.6979639597472502,6.569643650455949,"['CDC42', 'RALBP1', 'EXOC8', 'RAC1', 'HRAS', 'EXOC2']",0.7842069269468361,0,0,6
67,Alzheimer's disease WP2059,0.08845431667582158,1.4323046983597443,3.473724263690397,"['ATP5MD', 'GSK3B', 'PSEN2', 'ITPR1', 'ATP2A2', 'ITPR2', 'ATP2A1', 'IDE', 'CACNA1C', 'HSD17B10', 'PPP3CA', 'GRIN2A', 'PPP3CC', 'PPP3R2', 'MAPK1', 'FADD', 'APOE', 'MME', 'ADAM10', 'GRIN2B', 'BACE1', 'PLCB4', 'GNAQ', 'CYCS', 'CALM3', 'PLCB1', 'CALM1', 'ATF6']",0.7842069269468361,0,0,28
68,Sulindac Metabolic Pathway WP2542,0.08987649800806974,6.742984097287184,16.245998322651435,"['MSRA', 'MSRB2', 'MSRB3']",0.7850976443646092,0,0,3
69,Gastrin signaling pathway WP4659,0.09624743834266987,1.3435156879743273,3.144945752008172,"['GSK3B', 'CDKN1B', 'ROCK1', 'PXN', 'PIK3R3', 'CLDN1', 'FOXO1', 'EGFR', 'CDC42', 'MAPK8', 'CCND1', 'KAT5', 'MAPK1', 'FYN', 'RAC1', 'PRKACA', 'JAK2', 'HRAS', 'MEF2D', 'MEF2C', 'YES1', 'PRKCE', 'RPS6', 'PRKCA', 'PTK2', 'NFKB1', 'RHOB', 'TJP1', 'BMP2', 'CREB1', 'PIK3CA', 'RPS6KB1', 'GNAQ', 'TCF4', 'PPARG', 'PRKD1', 'SOS1']",0.8285649039934188,0,0,37
70,16p11.2 proximal deletion syndrome WP4949,0.10021191771686454,1.427090203185126,3.2829755711838553,"['KMT2C', 'QPRT', 'NR3C1', 'SEZ6L2', 'PPP2CB', 'PPP4R1', 'HIRIP3', 'PPP4R4', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'BPTF', 'CCT3', 'MAP2K3', 'CCT2', 'IGFBP3', 'KIF22', 'NFKB1', 'CCT6A', 'ASPHD1', 'TCP1', 'KCTD13', 'TMEM219', 'PPARG', 'ALDOA']",0.850369701768822,0,0,26
71,Genotoxicity pathway WP4286,0.1032840334477148,1.5266264252179744,3.4658579599317707,"['IKBIP', 'TIGAR', 'NLRX1', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'TRIAP1', 'PPM1D', 'COIL', 'MEX3B', 'RPS27', 'RRM2B', 'BLOC1S2', 'BRMS1L', 'RAPGEF2', 'LRRFIP2']",0.8510679386019391,0,0,19
72,TNF-alpha signaling pathway WP231,0.10481501155284188,1.3779472721072425,3.1080403753464987,"['TRADD', 'OTUD7B', 'TXN', 'MAPK8', 'TBK1', 'MAPK1', 'RAC1', 'FADD', 'BTRC', 'MAP3K7', 'HRAS', 'MAP3K5', 'SKP1', 'MAP2K3', 'MAP2K4', 'HSP90AA1', 'CREBBP', 'MAP3K1', 'KSR1', 'FBXW11', 'KSR2', 'CFLAR', 'NFKB1', 'CDC37', 'MADD', 'BAX', 'TAB2', 'SOS1', 'NFKBIE', 'NFKBIB']",0.8510679386019391,0,0,30
73,Transcription co-factors SKI and SKIL protein partners WP4533,0.1052356330613535,2.248361423220974,5.062305624128552,"['LATS1', 'PRMT5', 'HDAC1', 'SATB2', 'NF1', 'MERTK', 'TEAD1']",0.8510679386019391,0,0,7
74,Physiological and pathological hypertrophy of the heart WP1528,0.10632217151580774,1.8739751698289997,4.200105767994226,"['MAP2K3', 'PPP3CA', 'CAMK2D', 'MAPK8', 'PRKCE', 'MAPK1', 'LIFR', 'RAC1', 'IL6ST', 'CALM1']",0.8510679386019391,0,0,10
75,Biotin Metabolism (including IEMs) WP5031,0.10889084736321106,2.810014038371549,6.230951258518954,"['PC', 'PCCA', 'HLCS', 'ACACB', 'ACACA']",0.8510679386019391,0,0,5
76,Osteoclast Signaling WP12,0.10889084736321106,2.810014038371549,6.230951258518954,"['AIMP2', 'ATP6V1G1', 'MAPK8', 'SPP1', 'IFNAR1']",0.8510679386019391,0,0,5
77,G13 Signaling Pathway WP524,0.11052495111618195,1.6066403109086036,3.5386477481098577,"['CYFIP1', 'ROCK1', 'ROCK2', 'PIK3CB', 'CDC42', 'GNA13', 'MAPK10', 'RPS6KB1', 'PIK3CA', 'CFL2', 'PIP4K2A', 'RAC1', 'PAK3', 'CALM1', 'MAP3K4']",0.8526210514676893,0,0,15
78,Proteoglycan biosynthesis WP4784,0.11888503190383573,1.9985951767735892,4.256205033383062,"['CSGALNACT1', 'EXT1', 'CANT1', 'CHSY1', 'B3GAT3', 'B3GALT6', 'B4GALT7', 'PAPSS2']",0.9053552429599797,0,0,8
79,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.12175798592770772,1.256638432829668,2.6461285882080348,"['CYFIP1', 'GRIA2', 'GSK3B', 'PRKAA1', 'RAB3A', 'DOCK3', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'MAPK8', 'RAP1A', 'CDH2', 'DPYSL2', 'NCK2', 'RACK1', 'SPP1', 'MAPK1', 'KCNN2', 'FYN', 'RAC1', 'JAK2', 'HRAS', 'GRIA3', 'MEF2A', 'VAV3', 'STAT5B', 'NTRK2', 'MEF2C', 'CDKL5', 'MAP3K1', 'KSR1', 'STAT1', 'NTRK3', 'RPS6', 'RANBP9', 'EIF2S2', 'GRIN2B', 'NFKB1', 'MAPK10', 'TIAM1', 'DLG1', 'BMP2', 'CREB1', 'RPS6KB1', 'APC', 'CAMK4', 'SQSTM1']",0.9101045648180773,0,0,48
80,Ebola Virus Pathway on Host WP4217,0.12257300536270402,1.3068963682117796,2.7432388147827216,"['TSG101', 'CLTC', 'VPS4A', 'PIK3R3', 'CLTA', 'PIK3CB', 'ASGR1', 'EGFR', 'IGF1R', 'ACTG1', 'CDC42', 'TBK1', 'CTSL', 'EP300', 'MAPK1', 'FLNB', 'RAC1', 'FLNC', 'CTSB', 'CREBBP', 'STAT1', 'VPS33A', 'HLA-B', 'DAB2IP', 'EIF2AK2', 'HLA-A', 'HLA-F', 'MERTK', 'NFKB1', 'RHOB', 'TIAM1', 'PIK3CA', 'RASA2', 'HLA-DRA', 'TLR4', 'CLEC4G']",0.9101045648180773,0,0,36
81,Melanoma WP4685,0.13216398270132465,1.3845069149416975,2.8018430283153357,"['RB1', 'GADD45A', 'PIK3R3', 'MITF', 'BRAF', 'PIK3CB', 'PREX2', 'GRIN2A', 'CREB1', 'CDK6', 'CCND1', 'PIK3CA', 'ERBB4', 'AKT3', 'NF1', 'MAPK1', 'BAX', 'CALM3', 'RAC1', 'SOS1', 'CALM1', 'HRAS', 'SOS2', 'VCL']",0.9650661573102213,0,0,24
82,mRNA Processing WP411,0.1356217901605695,1.2505904581955598,2.4985361951860146,"['SF3B5', 'TMED10', 'SF3B3', 'DHX8', 'SFSWAP', 'RNMT', 'CELF2', 'CSTF2T', 'SNU13', 'YBX1', 'SNRPD1', 'CLP1', 'DHX15', 'SNRPB2', 'TXNL4A', 'HNRNPA1', 'RBM5', 'SRPK2', 'RBM39', 'SF3A1', 'RNGTT', 'CPSF1', 'PRMT2', 'NCBP2', 'DICER1', 'SUPT5H', 'PTBP2', 'LSM2', 'PRPF4', 'HNRNPM', 'LSM7', 'HNRNPK', 'PRPF18', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPE', 'SNRPA1', 'SNRPF', 'SREK1', 'CLASRP', 'DNAJC8', 'RBMX', 'SNRPB', 'SRSF9']",0.9650661573102213,0,0,45
83,Pentose Phosphate Metabolism WP134,0.13664369268142576,2.9969590643274855,5.965082960184418,"['RPIA', 'TALDO1', 'PGLS', 'TKT']",0.9650661573102213,0,0,4
84,TGF-beta Signaling Pathway WP366,0.1368683548073197,1.264162470020105,2.5140850713176213,"['ROCK1', 'ZFYVE9', 'HDAC1', 'CDC42', 'MAPK8', 'CCND1', 'SUMO1', 'PRKAR2A', 'EP300', 'SNIP1', 'MAPK1', 'RAC1', 'BTRC', 'MAP3K7', 'SPTBN1', 'PDK1', 'SKP1', 'MEF2A', 'MAP2K3', 'SMAD2', 'MAP2K4', 'KLF11', 'MEF2C', 'CREBBP', 'TGFB1', 'SMURF2', 'SMURF1', 'WWP1', 'NUP153', 'PIAS2', 'RUNX2', 'PTK2', 'PIAS1', 'TGFBR3', 'ZEB2', 'ITCH', 'ZFYVE16', 'RBL1', 'ZEB1', 'STRAP', 'SOS1']",0.9650661573102213,0,0,41
85,Splicing factor NOVA regulated synaptic proteins WP4148,0.1384494039732096,1.499413558526859,2.964715959957813,"['NTNG1', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'CASK', 'GRIK2', 'ANK3', 'EFNA5', 'GRIN2B', 'PLCB4', 'CDH2', 'EPB41L3', 'STX2', 'NEO1', 'CLASP1']",0.9650661573102213,0,0,16
86,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.14376902443427442,1.445938243873001,2.804465565063742,"['GSK3B', 'NTRK2', 'PRKAA1', 'PRKAG1', 'PIK3R3', 'PIK3CB', 'CACNA1C', 'GRIN2B', 'GRM1', 'RPTOR', 'GRIN2A', 'PIK3CA', 'RPS6KB1', 'CAMK4', 'AKT3', 'NF1', 'MAPK1', 'HRAS']",0.9650661573102213,0,0,18
87,3q29 copy number variation syndrome WP4906,0.1490972046160839,1.3893432431685686,2.6441380487872004,"['DYNC2H1', 'STAT5B', 'TGFB1', 'DYNLT1', 'NCBP2', 'FBXW7', 'DYNLT3', 'CEP350', 'PXN', 'PIGZ', 'ADAM10', 'PIK3R3', 'MAD2L1BP', 'RABL2B', 'FBXO45', 'DYNLL2', 'PIGX', 'DLG1', 'WDR60', 'UBE2N', 'NF2']",0.9650661573102213,0,0,21
88,CAMKK2  Pathway WP4874,0.15080034222677377,1.587284081666414,3.0028217304877756,"['RPTOR', 'FIS1', 'MAP1LC3A', 'CREB1', 'STIM1', 'CAMK4', 'EP300', 'MAPK1', 'RAC1', 'ARHGEF7', 'CALM1', 'SQSTM1']",0.9650661573102213,0,0,12
89,Melatonin metabolism and effects WP3298,0.15080034222677377,1.587284081666414,3.0028217304877756,"['SULT1A1', 'GSK3B', 'PER3', 'MAP2', 'CRY2', 'CRY1', 'PRKCA', 'APOE', 'CALM1', 'CLOCK', 'FOXO1', 'NFKB1']",0.9650661573102213,0,0,12
90,PDGFR-beta pathway WP3972,0.15080034222677377,1.587284081666414,3.0028217304877756,"['STAT5B', 'MAP2K4', 'MAPK8', 'MAP3K1', 'PIK3CA', 'STAT1', 'RASA1', 'EIF2AK2', 'PRKCA', 'JAK2', 'SOS1', 'HRAS']",0.9650661573102213,0,0,12
91,Prion disease pathway WP3995,0.15080034222677377,1.587284081666414,3.0028217304877756,"['PDIA3', 'MEF2C', 'CREB1', 'HSPA5', 'RFX5', 'EP300', 'MAPK1', 'FYN', 'CHD2', 'NFKB1', 'PTK2', 'HSP90B1']",0.9650661573102213,0,0,12
92,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.15138523905519502,1.3615576770874556,2.5705220984427255,"['RB1', 'MAP2K3', 'CDKN1B', 'STAT1', 'PDE4D', 'RPS6', 'GNAI3', 'BRAF', 'TTF1', 'IGF1R', 'MYL12B', 'GNA13', 'CREB1', 'RAP1A', 'PIK3CA', 'RPS6KB1', 'APEX1', 'GNAQ', 'GNB1', 'MAPK1', 'JAK2', 'PLCB1', 'HRAS']",0.9650661573102213,0,0,23
93,G Protein Signaling Pathways WP35,0.15452425147365337,1.2980429784383656,2.423970945406561,"['ITPR1', 'GNAI3', 'AKAP6', 'AKAP5', 'ADCY8', 'ADCY5', 'GNA13', 'PPP3CA', 'GNG10', 'GNG3', 'PPP3CC', 'GNG4', 'PRKAR2B', 'PRKAR2A', 'PRKACA', 'HRAS', 'KCNJ3', 'PDE4D', 'PRKCE', 'PRKCA', 'ADCY9', 'GNAL', 'PRKAR1A', 'GNAQ', 'AKAP9', 'GNB1', 'PRKD1', 'GNB5', 'PDE7A', 'CALM1']",0.9650661573102213,0,0,30
94,"Relationship between inflammation, COX-2 and EGFR WP4483",0.15855433655239287,1.798548349332709,3.312310824727668,"['PIK3CA', 'PTGES2', 'AKT3', 'MAPK1', 'BRAF', 'PIK3CB', 'HRAS', 'EGFR']",0.9650661573102213,0,0,8
95,Cysteine and methionine catabolism WP4504,0.1643221092910467,2.2477772578380906,4.059320957491272,"['AHCY', 'GOT1', 'GSS', 'SUOX', 'CDO1']",0.9650661573102213,0,0,5
96,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.1643221092910467,2.2477772578380906,4.059320957491272,"['GABBR1', 'GRM5', 'GPRC5B', 'GRM8', 'GRM1']",0.9650661573102213,0,0,5
97,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.1643221092910467,2.2477772578380906,4.059320957491272,"['TIFA', 'UBE2N', 'UBE2V1', 'TLR4', 'NFKB1']",0.9650661573102213,0,0,5
98,TCA cycle in senescence WP5050,0.1643221092910467,2.2477772578380906,4.059320957491272,"['PDHA1', 'GOT1', 'ME1', 'BRAF', 'PDK1']",0.9650661573102213,0,0,5
99,Ciliary landscape WP4352,0.16746797443670083,1.1680942260639722,2.0873413299834507,"['RB1', 'IFT172', 'MYL6B', 'SMC4', 'RPGR', 'PSMD8', 'PSMD7', 'APMAP', 'BBS9', 'TMED1', 'CEP170', 'RAC1', 'IFT57', 'CEP290', 'BBS4', 'EXOC8', 'DYNLT1', 'IFT140', 'DYNLT3', 'ARMC8', 'DYNLL2', 'MYL6', 'IFT88', 'TBC1D4', 'TIPRL', 'EXOC4', 'CD2BP2', 'EXOC3', 'MCM4', 'MCM6', 'EXOC2', 'PAFAH1B1', 'ARL8B', 'ECHS1', 'PSMD13', 'HDAC1', 'VPS4A', 'COPS7B', 'COPS7A', 'EHBP1', 'EXOSC7', 'PGRMC2', 'RMND5A', 'SNRPB2', 'DCAF11', 'CDR2', 'CREBBP', 'UBE2H', 'RNGTT', 'NDUFA5', 'EXOC6B', 'LCA5', 'RANBP9', 'COX6C', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'MKLN1', 'COPS6', 'RAB14', 'MFAP1', 'APC', 'WNK1', 'WDR60', 'GLB1', 'GID8', 'CALM1', 'COPS8']",0.9650661573102213,0,0,69
100,NRF2-ARE regulation WP4357,0.16753027256461564,1.6861826697892273,3.0125191402083016,"['GSK3B', 'AIMP2', 'MAPK8', 'YES1', 'PIK3CA', 'INSR', 'KEAP1', 'PRKCA', 'FYN']",0.9650661573102213,0,0,9
101,DNA damage response (only ATM dependent) WP710,0.1729419847423566,1.2630587535473956,2.2164143501242366,"['GSK3B', 'CDKN1B', 'PIK3R3', 'PIK3CB', 'BBC3', 'CDC42', 'MAPK8', 'CCND2', 'CCND1', 'PPP2R5E', 'AKT3', 'ABL1', 'MAPK1', 'RAC1', 'MAP3K7', 'HRAS', 'MAP3K4', 'PDK1', 'WNT10B', 'TGFB1', 'MAP3K1', 'INSR', 'PPP2R5C', 'NFKB1', 'MAPK10', 'PIK3CA', 'APC', 'CCNG2', 'BAX', 'ATM', 'SOS1', 'SOS2']",0.9650661573102213,0,0,32
102,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.1730657745076715,1.3373838955234305,2.345883100902774,"['SCARB2', 'SMARCAL1', 'LAMA5', 'CDKN1B', 'TGFB1', 'MME', 'LAMB2', 'ILK', 'PARVA', 'CLDN1', 'PTK2', 'CD2AP', 'LRP6', 'YWHAQ', 'CDH2', 'CTSL', 'FAT1', 'PLCE1', 'FYN', 'TLR4', 'VCL', 'LIMS1']",0.9650661573102213,0,0,22
103,ACE Inhibitor Pathway WP554,0.17384188355588162,3.3711412535079512,5.898179441814474,"['TGFB1', 'ATP6AP2', 'NR3C2']",0.9650661573102213,0,0,3
104,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.17384188355588162,3.3711412535079512,5.898179441814474,"['PPARG', 'PPARA', 'CYP2C18']",0.9650661573102213,0,0,3
105,FTO Obesity Variant Mechanism WP3407,0.17384188355588162,3.3711412535079512,5.898179441814474,"['FTO', 'ARID5B', 'PPARGC1A']",0.9650661573102213,0,0,3
106,Mitochondrial fatty acid synthesis pathway WP4317,0.17384188355588162,3.3711412535079512,5.898179441814474,"['MECR', 'HSD17B12', 'ACACA']",0.9650661573102213,0,0,3
107,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.17384188355588162,3.3711412535079512,5.898179441814474,"['EPHA4', 'RIPPLY2', 'DLL3']",0.9650661573102213,0,0,3
108,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.17991654129400503,1.5457474226804124,2.6513621172861046,"['RPTOR', 'GSK3B', 'CDKN1B', 'PIK3CA', 'TFEB', 'PIK3R3', 'RICTOR', 'PIK3CB', 'HRAS', 'FOXO1', 'PDK1']",0.9708373386354356,0,0,11
109,Cori Cycle WP1946,0.1823026564615438,1.9267159239075926,3.2794381758703537,"['LDHA', 'PGAM1', 'PGK1', 'TALDO1', 'ALDOA', 'PFKP']",0.9708373386354356,0,0,6
110,miRNAs involved in DNA damage response WP1545,0.1823026564615438,1.9267159239075926,3.2794381758703537,"['CDKN1B', 'CREB1', 'CDK6', 'CCND1', 'ABL1', 'ATM']",0.9708373386354356,0,0,6
111,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.1823026564615438,1.9267159239075926,3.2794381758703537,"['GSK3B', 'LDHA', 'PDHA1', 'PIK3CA', 'HLA-DRA', 'SLC2A3']",0.9708373386354356,0,0,6
112,Kynurenine Pathway and links to Cellular Senescence WP5044,0.1946688347910809,1.7483614232209739,2.8611155748068087,"['HAAO', 'QPRT', 'AHR', 'EIF2AK4', 'KMO', 'TLR4', 'FOXO1']",0.9708373386354356,0,0,7
113,Transcription factor regulation in adipogenesis WP3599,0.1946688347910809,1.7483614232209739,2.8611155748068087,"['MAPK8', 'CREB1', 'INSR', 'PPARG', 'NR3C1', 'PPARGC1A', 'FOXO1']",0.9708373386354356,0,0,7
114,Translation Factors WP107,0.19679488012886165,1.3352406103286385,2.1705582038015034,"['EIF4A2', 'EIF2B2', 'EIF1AX', 'EIF2AK2', 'EIF2S2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.9708373386354356,0,0,19
115,Head and Neck Squamous Cell Carcinoma WP4674,0.19717786679591978,1.2852106765150244,2.0867311331157117,"['RB1', 'PRKAA1', 'RPS6', 'GAB1', 'KEAP1', 'PIK3CB', 'EGFR', 'NFKB1', 'IGF1R', 'RPTOR', 'CDK6', 'CCND1', 'PIK3CA', 'TRAF3', 'SESN1', 'SESN2', 'AKT3', 'NUMB', 'FAT1', 'RICTOR', 'FADD', 'CSMD3', 'HRAS', 'FGFR2']",0.9708373386354356,0,0,24
116,MECP2 and Associated Rett Syndrome WP3584,0.19717786679591978,1.2852106765150244,2.0867311331157117,"['MEF2C', 'RBFOX1', 'PRPF38A', 'GRID1', 'HDAC1', 'DLX6', 'GAD1', 'RPS6', 'TET2', 'TAP1', 'YBX1', 'IGF1R', 'GABRR2', 'FUT8', 'CREB1', 'NCOR1', 'SST', 'SP3', 'NF1', 'SGK1', 'GRIA3', 'CDON', 'FKBP5', 'GRIA4']",0.9708373386354356,0,0,24
117,DNA damage response WP707,0.19721116726612475,1.3228733616010386,2.1476587219408847,"['RB1', 'CDKN1B', 'MRE11', 'GADD45A', 'BBC3', 'PIDD1', 'CCND2', 'CREB1', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'TLK2', 'ABL1', 'TLK1', 'CYCS', 'BAX', 'ATM', 'RAD9A']",0.9708373386354356,0,0,20
118,Proteasome Degradation WP183,0.19743176880157937,1.3118835133865665,2.128350260642644,"['UBE2B', 'H2AFZ', 'PSMD13', 'HLA-B', 'HLA-A', 'HLA-F', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMA3', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMA1', 'PSMA2', 'PSMB3', 'PSME3', 'PSMC1', 'UBC', 'PSME2']",0.9708373386354356,0,0,21
119,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.20348324425486763,1.634873672335625,2.602999455699531,"['CREB1', 'RPS6KB1', 'RPS6', 'MAPK1', 'PRKCA', 'PRKACA', 'SGK1', 'FOXO1']",0.9708373386354356,0,0,8
120,Immune response to tuberculosis WP4197,0.20348324425486763,1.634873672335625,2.602999455699531,"['STAT1', 'IFNGR2', 'IRF1', 'TAP1', 'JAK2', 'IFIT3', 'PIAS1', 'IFNAR1']",0.9708373386354356,0,0,8
121,SARS-CoV-2 mitochondrial interactions WP5038,0.20990511472061402,1.556314177625653,2.429561572509171,"['TOMM70', 'NDUFB9', 'NLRX1', 'TBK1', 'CTSL', 'TRAF3', 'ACAD9', 'PHB', 'NFKB1']",0.9708373386354356,0,0,9
122,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.20990511472061402,1.556314177625653,2.429561572509171,"['ADAMTS2', 'CRTAP', 'BMP1', 'ITPR1', 'P3H2', 'PLOD2', 'P4HB', 'PPIB', 'LRP6']",0.9708373386354356,0,0,9
123,GABA receptor Signaling WP4159,0.21813750050845043,1.4546694966646452,2.2149229483884962,"['GABRA2', 'GABRB1', 'GABBR1', 'SLC32A1', 'GAD1', 'GABRA4', 'AP2S1', 'AP2B1', 'SLC6A1', 'GABRG3', 'AP2M1']",0.9708373386354356,0,0,11
124,The influence of laminopathies on Wnt signaling WP4844,0.21813750050845043,1.4546694966646452,2.2149229483884962,"['GSK3B', 'WNT10B', 'CDK6', 'CCND1', 'APC', 'SPP1', 'PPARG', 'DICER1', 'EMD', 'TARBP2', 'RUNX2']",0.9708373386354356,0,0,11
125,Hepatitis B infection WP4666,0.22183113612518218,1.1839932456761153,1.7829030092836389,"['YWHAB', 'PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'YWHAQ', 'AKT3', 'EP300', 'MAPK1', 'FADD', 'JAK2', 'MAP3K7', 'HRAS', 'MAP2K3', 'SMAD2', 'MAP2K4', 'STAT5B', 'CREBBP', 'TICAM2', 'TGFB1', 'MAP3K1', 'ATP6AP1', 'STAT1', 'PRKCA', 'BRAF', 'NFKB1', 'DDB1', 'MAPK10', 'CREB3', 'CREB1', 'PIK3CA', 'TRAF3', 'CYCS', 'BAX', 'TAB2', 'SOS1', 'SOS2', 'TLR4', 'IFNAR1', 'ATF4']",0.9708373386354356,0,0,40
126,Prolactin Signaling Pathway WP2037,0.2218726551616117,1.2551908835023091,1.8898802713702543,"['GSK3B', 'STAT5B', 'STAT1', 'RPS6', 'PXN', 'PIK3CB', 'GAB2', 'CBL', 'PTK2', 'NFKB1', 'SOCS2', 'MAPK8', 'PIK3CA', 'RPS6KB1', 'RPS6KA2', 'IRF1', 'MAPK1', 'FYN', 'RAC1', 'JAK2', 'SOS1', 'PPIB', 'HRAS', 'NFKBIB']",0.9708373386354356,0,0,24
127,DNA Replication WP466,0.22256353465958043,1.3917688031612083,2.09119201227945,"['PRIM2', 'CDC7', 'ORC5', 'POLD4', 'POLA1', 'ORC6', 'RPA3', 'UBC', 'POLD2', 'ORC2', 'MCM4', 'MCM6', 'UBA52']",0.9708373386354356,0,0,13
128,Vitamin D-sensitive calcium signaling in depression WP4698,0.22256353465958043,1.3917688031612083,2.09119201227945,"['CHRM1', 'GPX4', 'ITPR1', 'ITPR2', 'ATP2B3', 'ATP2B2', 'CACNA1C', 'GRIN2B', 'SLC8A1', 'GRIN2A', 'GRM5', 'CALB1', 'KCNQ3']",0.9708373386354356,0,0,13
129,Copper homeostasis WP3286,0.2238594015002824,1.3685305061420052,2.0483303756452265,"['GSK3B', 'COX17', 'ADAM10', 'FOXO1', 'ATOX1', 'SOD1', 'BACE1', 'CCS', 'ATP7B', 'CCND1', 'PIK3CA', 'APC', 'SCO2', 'COX11']",0.9708373386354356,0,0,14
130,IL-3 signaling pathway WP286,0.22470963020842746,1.349015009380863,2.0140068895185,"['STAT5B', 'TGFB1', 'YWHAB', 'GAB2', 'CBL', 'HCK', 'MAPK8', 'YWHAQ', 'MAPK1', 'FYN', 'ENPP3', 'JAK2', 'PRKACA', 'SOS1', 'HRAS']",0.9708373386354356,0,0,15
131,Cardiac Hypertrophic Response WP2795,0.22535607333454927,1.3055999273228305,1.9454399571451528,"['MEF2A', 'MAP2K3', 'GSK3B', 'MAP2K4', 'CAMK2D', 'TGFB1', 'MAP3K1', 'PRKCA', 'NFKB1', 'PPP3CA', 'MAPK8', 'MAPK1', 'RAC1', 'PRKD1', 'CALM1', 'MAP3K7', 'PRKG1', 'FGFR2']",0.9708373386354356,0,0,18
132,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2261903387338721,4.494271685761047,6.680188480499693,"['TGFB1', 'VIP']",0.9708373386354356,0,0,2
133,Gastric acid production WP2596,0.2261903387338721,4.494271685761047,6.680188480499693,"['CCK', 'VIP']",0.9708373386354356,0,0,2
134,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.22826182555470492,1.872952737482452,2.766841815459915,"['BMP2', 'BMPR2', 'SMURF1', 'RUNX2', 'BMPR1A']",0.9708373386354356,0,0,5
135,Computational Model of Aerobic Glycolysis WP4629,0.22826182555470492,1.872952737482452,2.766841815459915,"['LDHA', 'PKM', 'PGK1', 'ALDOA', 'PFKM']",0.9708373386354356,0,0,5
136,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.22826182555470492,1.872952737482452,2.766841815459915,"['GALNT3', 'CCND1', 'SPP1', 'NFKB1', 'FGFR2']",0.9708373386354356,0,0,5
137,Leptin Insulin Overlap WP3935,0.22826182555470492,1.872952737482452,2.766841815459915,"['SOCS2', 'INSR', 'LEPR', 'PIK3R3', 'JAK2']",0.9708373386354356,0,0,5
138,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.22826182555470492,1.872952737482452,2.766841815459915,"['ZEB1', 'IL6ST', 'JAK2', 'NFKB1', 'SOX4']",0.9708373386354356,0,0,5
139,RAS and bradykinin pathways in COVID-19 WP4969,0.22826182555470492,1.872952737482452,2.766841815459915,"['ROCK1', 'MAPK1', 'KLKB1', 'PRKG1', 'NFKB1']",0.9708373386354356,0,0,5
140,ERK Pathway in Huntington's Disease WP3853,0.24010292497696029,1.6857009127076996,2.4049685785135595,"['NTRK2', 'CREB1', 'MAPK1', 'HRAS', 'GRM1', 'EGFR']",0.9708373386354356,0,0,6
141,TP53 network WP1742,0.24010292497696029,1.6857009127076996,2.4049685785135595,"['SUMO1', 'GADD45A', 'ABL1', 'BAX', 'ATM', 'BBC3']",0.9708373386354356,0,0,6
142,Non-small cell lung cancer WP4255,0.24633145027163805,1.2221234234786698,1.7122893755517123,"['ALK', 'RB1', 'CRABP2', 'CRABP1', 'PIK3R3', 'PIK3CB', 'FHIT', 'EGFR', 'CCND1', 'AKT3', 'MAPK1', 'HRAS', 'PDK1', 'STAT5B', 'GADD45A', 'PRKCA', 'BRAF', 'EML4', 'CDK6', 'PIK3CA', 'RARB', 'CYCS', 'BAX', 'SOS1', 'SOS2']",0.9708373386354356,0,0,25
143,Ebstein-Barr virus LMP1 signaling WP262,0.24771749623741057,1.5733614232209738,2.1955728598600315,"['HSP90AA1', 'MAPK8', 'TRADD', 'MAPK1', 'MAP3K7', 'NFKB1', 'PDLIM7']",0.9708373386354356,0,0,7
144,Imatinib and Chronic Myeloid Leukemia WP3640,0.24771749623741057,1.5733614232209738,2.1955728598600315,"['ABCB1', 'CDKN1B', 'GADD45A', 'ABL1', 'GAB2', 'PIM2', 'SKP2']",0.9708373386354356,0,0,7
145,Toll-like Receptor Signaling Pathway WP75,0.2509401993959179,1.2366925064599483,1.7097776217303338,"['MAP2K3', 'MAP2K4', 'TICAM2', 'STAT1', 'PIK3R3', 'PIK3CB', 'NFKB1', 'MAPK10', 'MAPK8', 'TBK1', 'PIK3CA', 'TRAF3', 'AKT3', 'SPP1', 'MAPK1', 'TAB2', 'FADD', 'RAC1', 'MAP3K7', 'TLR4', 'IFNAR1', 'NFKBIB']",0.9708373386354356,0,0,22
146,Ciliopathies WP4803,0.2515608911444664,1.1355351227097559,1.5671181916724486,"['C2CD3', 'IFT172', 'CEP120', 'PKD2', 'PKD1', 'CCDC28B', 'GLI3', 'TCTN3', 'CSPP1', 'SUFU', 'NEK1', 'BBS9', 'IFT57', 'CEP290', 'BBS4', 'DYNC2H1', 'IFT140', 'DNAAF5', 'RPGRIP1L', 'CFAP410', 'POMGNT1', 'NME7', 'EFHC1', 'CCDC151', 'SDCCAG8', 'ARL6', 'ARL3', 'AK7', 'TTBK2', 'TTC21B', 'TMEM67', 'INPP5E', 'NPHP4', 'RAB28', 'PIBF1', 'DNAI1', 'CEP78', 'WDR19', 'LCA5', 'SCLT1', 'CPLANE1', 'AHI1', 'TTLL5', 'RSPH1', 'TMEM17', 'WDR60', 'TMEM237', 'KIAA0586', 'ALMS1', 'SPAG1', 'CCDC65', 'CEP41', 'TRIM32']",0.9708373386354356,0,0,53
147,MET in type 1 papillary renal cell carcinoma WP4205,0.25377936117165656,1.2491195116224465,1.712905152888321,"['ALK', 'RPL11', 'GAB1', 'PIK3R3', 'BRAF', 'PIK3CB', 'CBL', 'PTK2', 'CDC42', 'MAPK8', 'RAP1A', 'PIK3CA', 'AKT3', 'MAPK1', 'RAC1', 'SOS1', 'PAK3', 'HRAS', 'SOS2', 'PAK5']",0.9708373386354356,0,0,20
148,miRNA regulation of DNA damage response WP1530,0.25377936117165656,1.2491195116224465,1.712905152888321,"['RB1', 'CDKN1B', 'MRE11', 'GADD45A', 'BBC3', 'PIDD1', 'CCND2', 'CREB1', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'TLK2', 'ABL1', 'TLK1', 'CYCS', 'BAX', 'ATM', 'RAD9A']",0.9708373386354356,0,0,20
149,Cell migration and invasion through p75NTR WP4561,0.2559926699985707,1.4449983271997324,1.9689640665022314,"['NTRK2', 'TIAM1', 'ARF1', 'EFNA3', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5']",0.9708373386354356,0,0,9
150,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2574160395804806,1.2740028155795402,1.7289003909526957,"['STAT5B', 'MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'IFT88', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5', 'BMPR1A']",0.9708373386354356,0,0,17
151,Endochondral Ossification WP474,0.2574160395804806,1.2740028155795402,1.7289003909526957,"['STAT5B', 'MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'IFT88', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5', 'BMPR1A']",0.9708373386354356,0,0,17
152,Genes controlling nephrogenesis WP4823,0.25807020964490013,1.4048957601311782,1.9029644635854934,"['EMX2', 'LAMB2', 'NCK2', 'ITGA8', 'ILK', 'SLIT2', 'ETV4', 'GLI3', 'FGFR2', 'CD2AP']",0.9708373386354356,0,0,10
153,Lipid Metabolism Pathway WP3965,0.25807020964490013,1.4048957601311782,1.9029644635854934,"['ACLY', 'PRKAA1', 'PDHA1', 'PRKAR2B', 'PRKAR1A', 'PRKAR2A', 'AKT3', 'PRKAG1', 'PRKACA', 'ACACA']",0.9708373386354356,0,0,10
154,Cytosolic DNA-sensing pathway WP4655,0.25837553268549485,1.284675446533293,1.7386042095309688,"['NLRX1', 'POLR3GL', 'TRADD', 'ADAR', 'ISG15', 'NFKB1', 'TBK1', 'POLR3A', 'POLR1C', 'POLR2E', 'TRIM25', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L', 'NFKBIB']",0.9708373386354356,0,0,16
155,Histone Modifications WP2369,0.2591549463690513,1.2969945158031462,1.751369499008821,"['KMT2E', 'SETD5', 'SETD2', 'SET', 'H3F3B', 'SETD9', 'EED', 'SMYD5', 'KMT2C', 'EHMT1', 'ASH1L', 'SETBP1', 'NSD1', 'SMYD3', 'HIST1H4C']",0.9708373386354356,0,0,15
156,Aryl Hydrocarbon Receptor Netpath WP2586,0.2597079076484384,1.3113716295427902,1.7679882300210366,"['RB1', 'HSP90AA1', 'CDKN1B', 'AIP', 'ARNT', 'AHR', 'EGFR', 'NFKB1', 'CDC37', 'NF1', 'EP300', 'MAPK1', 'NCOA7', 'HRAS']",0.9708373386354356,0,0,14
157,Interleukin-11 Signaling Pathway WP2332,0.2597079076484384,1.3113716295427902,1.7679882300210366,"['ATF1', 'TGFB1', 'YES1', 'STAT1', 'RPS6', 'RUNX2', 'PIAS1', 'CREB1', 'RPS6KB1', 'MAPK1', 'FYN', 'JAK2', 'IL6ST', 'HRAS']",0.9708373386354356,0,0,14
158,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.25987060074584895,1.3487696273728615,1.8175634577080102,"['GABRA2', 'NTRK2', 'GABRB1', 'CREB1', 'ROCK1', 'PIK3CA', 'GABRA4', 'PIK3R3', 'PIK3CB', 'AP2B1', 'JAK2', 'GABRG3']",0.9708373386354356,0,0,12
159,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.25987060074584895,1.3487696273728615,1.8175634577080102,"['STAT5B', 'HCK', 'MAPK8', 'YES1', 'PIK3CA', 'STAT1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'JAK2', 'NFKB1']",0.9708373386354356,0,0,12
160,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.263920610621682,1.154121151936445,1.5374127942515796,"['RYR2', 'ADCYAP1R1', 'DLX2', 'CHRNA4', 'YWHAB', 'HDAC1', 'ATP1A3', 'RORA', 'YBX1', 'NR3C1', 'HSP90B1', 'HSPD1', 'SOX2', 'YWHAQ', 'DEAF1', 'MAP2', 'PRKAR2B', 'PRKAR2A', 'EP300', 'TPPP', 'PRKACA', 'SCN3B', 'TAC1', 'PPARGC1A', 'SPTBN1', 'CHRNB2', 'NTRK2', 'MEF2C', 'CREBBP', 'MBD1', 'NFKB1', 'GCK', 'CREB1', 'PRKAR1A', 'SST', 'SP3', 'ALDOA', 'SLC25A4', 'CC2D1A']",0.974485507846173,0,0,39
161,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.2706909490436426,2.2471936389148737,2.9365821265942764,"['AHCY', 'MAT2B', 'CDO1']",0.974485507846173,0,0,3
162,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.2706909490436426,2.2471936389148737,2.9365821265942764,"['PRKAA1', 'CTDSP1', 'STRADB']",0.974485507846173,0,0,3
163,Peroxiredoxin 2 induced ovarian failure WP4873,0.2706909490436426,2.2471936389148737,2.9365821265942764,"['MAPK10', 'STAR', 'BAX']",0.974485507846173,0,0,3
164,Pilocytic astrocytoma WP2253,0.2706909490436426,2.2471936389148737,2.9365821265942764,"['NF1', 'BRAF', 'SOS1']",0.974485507846173,0,0,3
165,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.2728714843764135,1.1959957586851924,1.5533046915860507,"['GSK3B', 'THRA', 'ITPR2', 'TTF1', 'ADCY8', 'FOXO1', 'RPTOR', 'RPS6KA6', 'NHSL1', 'AKT3', 'MAPK1', 'PRKACA', 'MAP4K5', 'HRAS', 'PPARGC1A', 'RPS6', 'CREB3', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'ZNF516', 'PPARG', 'SOS1', 'PLCB1', 'MGLL']",0.974485507846173,0,0,25
166,Regulation of Actin Cytoskeleton WP51,0.27736545799322354,1.1380466401835807,1.4594529750196035,"['CYFIP2', 'NCKAP1', 'CHRM1', 'ROCK1', 'ROCK2', 'PXN', 'PIK3R3', 'BRK1', 'PIK3CB', 'FGF1', 'ARHGAP35', 'FGD1', 'EGFR', 'ACTG1', 'CDC42', 'GNA13', 'CFL2', 'TMSB4X', 'PIP4K2A', 'MAPK1', 'RAC1', 'PAK3', 'MAPK6', 'MYH10', 'PAK5', 'PPP1R12A', 'BRAF', 'ARPC5', 'SSH2', 'PTK2', 'DIAPH3', 'FGF14', 'MRAS', 'PIK3CA', 'APC', 'SOS1', 'ARHGEF7', 'FGF12', 'SOS2', 'VCL', 'FGFR2', 'ARHGEF6']",0.974485507846173,0,0,42
167,Thiamine metabolic pathways WP4297,0.28889022874411807,1.7978011695906433,2.23234498344948,"['BCKDK', 'PDHA1', 'SLC25A19', 'TKT']",0.974485507846173,0,0,4
168,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.2910141910426934,1.2327772816033666,1.5217196231139343,"['RB1', 'SMAD2', 'GSK3B', 'WNT10B', 'CREBBP', 'TGFB1', 'HDAC1', 'DICER1', 'LEMD3', 'RUNX2', 'TARBP2', 'KAT2B', 'BMP2', 'APC', 'SPP1', 'PPARG', 'EMD']",0.974485507846173,0,0,17
169,Cell Differentiation - Index expanded WP2023,0.297799242513345,1.6052209372284243,1.9444614314150643,"['MEF2A', 'SOX2', 'MEF2C', 'MEF2D', 'RUNX2']",0.974485507846173,0,0,5
170,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.297799242513345,1.6052209372284243,1.9444614314150643,"['GSK3B', 'APC', 'TNKS', 'TCF4', 'DKK3']",0.974485507846173,0,0,5
171,Glycogen Synthesis and Degradation WP500,0.2993747308099363,1.2704804419168756,1.5322746380870955,"['GSK3B', 'AGL', 'PPP2R5B', 'PHKA1', 'PHKB', 'PPP2R5C', 'PHKA2', 'PPP2CB', 'PPP2R5E', 'PPP2R2B', 'CALM3', 'CALM1', 'GYG1']",0.974485507846173,0,0,13
172,Hedgehog Signaling Pathway WP4249,0.2993747308099363,1.2704804419168756,1.5322746380870955,"['CSNK1G3', 'SMURF2', 'SMURF1', 'HHIP', 'FBXL17', 'GLI3', 'GRK3', 'CCND2', 'CCND1', 'SUFU', 'PRKACA', 'CDON', 'CSNK1G1']",0.974485507846173,0,0,13
173,Oxidative Damage WP3941,0.30117368368891245,1.2844085841507917,1.541377844246165,"['CDC42', 'MAPK10', 'MAP2K4', 'CDKN1B', 'MAP3K1', 'GADD45A', 'TRAF3', 'TDP2', 'CYCS', 'MAP3K9', 'NFKBIE', 'NFKB1']",0.974485507846173,0,0,12
174,Canonical and non-canonical TGF-B signaling WP3874,0.30232894466727833,1.4982447928855605,1.7922598021223084,"['SMAD2', 'MAPK8', 'TGFB1', 'BMPR2', 'BMP1', 'BMPR1A']",0.974485507846173,0,0,6
175,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.30232894466727833,1.4982447928855605,1.7922598021223084,"['GSK3B', 'MAP3K1', 'ROCK1', 'MAPK1', 'FGFR2', 'MAP3K4']",0.974485507846173,0,0,6
176,Overview of interferons-mediated signaling pathway WP4558,0.30232894466727833,1.4982447928855605,1.7922598021223084,"['PIK3CA', 'STAT1', 'IFNGR2', 'PRKCA', 'JAK2', 'IFNAR1']",0.974485507846173,0,0,6
177,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.3027583423539588,1.3012750949538796,1.554789953561926,"['PLCB4', 'STAR', 'PIK3CA', 'PRKCE', 'MAPK1', 'PRKCA', 'PIK3CB', 'PLCB1', 'HRAS', 'NFKB1', 'PDK1']",0.974485507846173,0,0,11
178,miRNA regulation of prostate cancer signaling pathways WP3981,0.3027583423539588,1.3012750949538796,1.554789953561926,"['GSK3B', 'CREBBP', 'CDKN1B', 'CCND1', 'PIK3CA', 'AKT3', 'PLCL2', 'MAPK1', 'SOS1', 'FOXO1', 'NFKB1']",0.974485507846173,0,0,11
179,IL17 signaling pathway WP2112,0.30404294982842267,1.3221170407727392,1.5740944426486079,"['GSK3B', 'TRAF3IP2', 'PIK3CA', 'TRAF3', 'MAPK1', 'IL17RE', 'JAK2', 'MAP3K7', 'NFKB1', 'NFKBIB']",0.974485507846173,0,0,10
180,Hippo-Yap signaling pathway WP4537,0.30445768130359,1.4301796050391555,1.7008027366558562,"['LATS1', 'YWHAQ', 'NF2', 'TNIK', 'TEAD1', 'MAP4K3', 'MAP4K4']",0.974485507846173,0,0,7
181,miRNAs involvement in the immune response in sepsis WP4329,0.30445768130359,1.4301796050391555,1.7008027366558562,"['MAPK8', 'TRAF3', 'IRF1', 'TAB2', 'MAP3K7', 'TLR4', 'NFKB1']",0.974485507846173,0,0,7
182,One-carbon metabolism WP241,0.30445768130359,1.4301796050391555,1.7008027366558562,"['AHCYL2', 'AHCY', 'CHDH', 'DNMT3A', 'AMT', 'GLRX', 'MAT2B']",0.974485507846173,0,0,7
183,Angiogenesis WP1539,0.30514192669930673,1.383066476955496,1.6416698640260106,"['CREBBP', 'ANGPT1', 'PIK3CA', 'TIMP2', 'ARNT', 'MAPK1', 'PTK2', 'FGFR2']",0.974485507846173,0,0,8
184,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.30514192669930673,1.383066476955496,1.6416698640260106,"['SMAD2', 'TGFBR3', 'MAPK8', 'MAPK1', 'NR2C2', 'RUNX2', 'FBN1', 'ENG']",0.974485507846173,0,0,8
185,Type II interferon signaling (IFNG) WP619,0.30514192669930673,1.383066476955496,1.6416698640260106,"['STAT1', 'IFNGR2', 'IRF1', 'HLA-B', 'TAP1', 'EIF2AK2', 'ISG15', 'JAK2']",0.974485507846173,0,0,8
186,Vitamin B12 metabolism WP1533,0.30514192669930673,1.383066476955496,1.6416698640260106,"['ABCA1', 'CUBN', 'MMAB', 'INSR', 'APOA1', 'APOE', 'NFKB1', 'SOD1']",0.974485507846173,0,0,8
187,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.3329413952444921,1.2041007772715089,1.3242565425888482,"['SMAD2', 'TGFB1', 'ADCY8', 'LEMD3', 'SYNE1', 'ADCY5', 'ADCY9', 'MAPK1', 'BANF1', 'MAP3K9', 'SOS1', 'HRAS', 'EMD', 'SOS2', 'PLEC']",0.9998978587529065,0,0,15
188,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3402788601291419,1.21741678387248,1.3123629005428656,"['SGMS1', 'ACTG1', 'LATS1', 'MAPK10', 'MAPK8', 'YWHAQ', 'NF2', 'PAK3', 'MAP4K5', 'TEAD1', 'PAK5', 'MAP4K3', 'MAP4K4']",0.9998978587529065,0,0,13
189,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.3440519387112065,1.225898544858001,1.3079879580670895,"['RPTOR', 'SMAD2', 'GSK3B', 'MAP1LC3A', 'EIF2B2', 'RPS6KB1', 'ILK', 'RICTOR', 'PPARGC1A', 'NFKB1', 'IGF1R', 'PDK1']",0.9998978587529065,0,0,12
190,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.34425610878726515,1.1512962687165622,1.2277071070619618,"['PRKN', 'HSPA9', 'HSPA8', 'PSMD14', 'HSPA5', 'FBXW7', 'PSMD13', 'HSPA4', 'CASK', 'UBE2L6', 'UBE2G1', 'UBE2G2', 'HSPA2', 'HSPA14', 'PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'RNF19A', 'PSMC1']",0.9998978587529065,0,0,21
191,Neural Crest Cell Migration in Cancer WP4565,0.3478861669953501,1.2360824742268042,1.3051547122737306,"['NTRK2', 'TIAM1', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CB', 'RAC1', 'PAK3', 'PAK5']",0.9998978587529065,0,0,11
192,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3478861669953501,1.2360824742268042,1.3051547122737306,"['EGLN1', 'LDHA', 'PDHA1', 'PKM', 'ANGPT1', 'IGFBP3', 'PGK1', 'ARNT', 'BAX', 'SLC2A3', 'HIF1AN']",0.9998978587529065,0,0,11
193,Neural Crest Cell Migration during Development WP4564,0.35176818961070355,1.248535956898571,1.3044489835518482,"['TIAM1', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CB', 'RAC1', 'PAK3', 'PAK5']",0.9998978587529065,0,0,10
194,EPO Receptor Signaling WP581,0.3595629497858614,1.284142221627588,1.31350543491851,"['STAT5B', 'STAT1', 'RASA1', 'MAPK1', 'JAK2', 'SOS1', 'EPOR', 'PDK1']",0.9998978587529065,0,0,8
195,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3595629497858614,1.284142221627588,1.31350543491851,"['TTC9', 'PNCK', 'CCND1', 'ERBB4', 'TPM3', 'NR3C1', 'JAK2', 'EGFR']",0.9998978587529065,0,0,8
196,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.36250412531357284,2.2469020341360766,2.279975139158974,"['TRAF3', 'NFKB1']",0.9998978587529065,0,0,2
197,Composition of Lipid Particles WP3601,0.36250412531357284,2.2469020341360766,2.279975139158974,"['APOA1', 'APOE']",0.9998978587529065,0,0,2
198,Gene regulatory network modelling somitogenesis  WP2854,0.36250412531357284,2.2469020341360766,2.279975139158974,"['EPHA4', 'RIPPLY2']",0.9998978587529065,0,0,2
199,Macrophage markers WP4146,0.36250412531357284,2.2469020341360766,2.279975139158974,"['CD74', 'CD83']",0.9998978587529065,0,0,2
200,Platelet-mediated interactions with vascular and circulating cells WP4462,0.36250412531357284,2.2469020341360766,2.279975139158974,"['TGFB1', 'TLR4']",0.9998978587529065,0,0,2
201,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.36250412531357284,2.2469020341360766,2.279975139158974,"['SLIT2', 'RAC1']",0.9998978587529065,0,0,2
202,Vitamin B6-dependent and responsive disorders WP4228,0.36250412531357284,2.2469020341360766,2.279975139158974,"['PNPO', 'PIGV']",0.9998978587529065,0,0,2
203,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.36335942225948237,1.3108614232209739,1.3270673285293644,"['ATF1', 'CREB1', 'RAP1A', 'MAPK1', 'BRAF', 'HTR4', 'NR3C1']",0.9998978587529065,0,0,7
204,Urea cycle and metabolism of amino groups WP497,0.3669249945227607,1.3482798970278493,1.3517824941554986,"['ODC1', 'SMS', 'PYCR1', 'PYCR3', 'ALDH18A1', 'SRM']",0.9998978587529065,0,0,6
205,Amino Acid metabolism WP3925,0.36692700535691863,1.1238251879699248,1.1267385319199525,"['WARS', 'PDHA1', 'HIBADH', 'PPM1L', 'GOT1', 'MDH2', 'MARS2', 'GSS', 'ODC1', 'PYCR1', 'HNMT', 'GLS', 'SRM', 'ACLY', 'LDHA', 'PKM', 'PC', 'AUH', 'RARS', 'SMS', 'IARS', 'ALDH18A1', 'BCAT1']",0.9998978587529065,0,0,23
206,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.36998458989754246,1.4044220870379036,1.3964083466608452,"['RB1', 'CDK8', 'H2AFY', 'CCND1', 'SOX4']",0.9998978587529065,0,0,5
207,Phytochemical activity on NRF2 transcriptional activation WP3,0.36998458989754246,1.4044220870379036,1.3964083466608452,"['AIMP2', 'MAPK8', 'PIK3CA', 'KEAP1', 'PRKCA']",0.9998978587529065,0,0,5
208,Type II diabetes mellitus WP1584,0.36998458989754246,1.4044220870379036,1.3964083466608452,"['SURF1', 'MAPK8', 'INSR', 'MAPK1', 'PHKA2']",0.9998978587529065,0,0,5
209,Aspirin and miRNAs WP4707,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['PPARA', 'NFKB1', 'PDK1']",0.9998978587529065,0,0,3
210,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['MRE11', 'DROSHA', 'ATM']",0.9998978587529065,0,0,3
211,LTF danger signal response pathway WP4478,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['MAPK1', 'TLR4', 'NFKB1']",0.9998978587529065,0,0,3
212,NAD Biosynthesis II (from tryptophan) WP2485,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['HAAO', 'QPRT', 'KMO']",0.9998978587529065,0,0,3
213,Sulfation Biotransformation Reaction WP692,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['SULT1A1', 'SULT4A1', 'PAPSS2']",0.9998978587529065,0,0,3
214,Vitamin B12 Disorders WP4271,0.3712263615943759,1.6852198316183349,1.6699572394320759,"['CUBN', 'MMAB', 'CD320']",0.9998978587529065,0,0,3
215,RANKL/RANK signaling pathway WP2018,0.37150993638660046,1.1624587565504303,1.1510430262240692,"['STAT1', 'MITF', 'GAB2', 'CBL', 'PAPSS2', 'PTK2', 'NFKB1', 'CDC42', 'MAPK8', 'TRAF3', 'MAPK1', 'TAB2', 'RAC1', 'MAP3K7', 'SQSTM1']",0.9998978587529065,0,0,15
216,15q13.3 copy number variation syndrome WP4942,0.371935618846782,1.4980116959064327,1.4815852595950938,"['KAT2B', 'CREBBP', 'OTUD7A', 'FYN']",0.9998978587529065,0,0,4
217,Pancreatic adenocarcinoma pathway WP4263,0.37781505934463677,1.1033909176430343,1.0739860617525796,"['RB1', 'PEBP1', 'PIK3R3', 'PIK3CB', 'EGFR', 'CDC42', 'MAPK8', 'CCND1', 'AKT3', 'MAPK1', 'RAC1', 'PAK3', 'PAK5', 'SMAD2', 'RALBP1', 'TGFB1', 'STAT1', 'GADD45A', 'BRAF', 'NFKB1', 'MAPK10', 'TIAM1', 'CDK6', 'PIK3CA', 'RPS6KB1', 'BAX', 'ARHGEF6']",0.9998978587529065,0,0,27
218,Adipogenesis WP236,0.38186557114017344,1.0897960057366698,1.0491320553964993,"['RB1', 'RORA', 'AHR', 'NR3C1', 'FOXO1', 'NDN', 'PPARGC1A', 'MEF2D', 'MEF2A', 'NCOA1', 'GDF10', 'STAT5B', 'WNT10B', 'NCOA2', 'MEF2C', 'MBNL1', 'TGFB1', 'GADD45A', 'STAT1', 'LIFR', 'BSCL2', 'KLF7', 'BMP2', 'BMP1', 'RBL1', 'CREB1', 'NCOR1', 'DDIT3', 'TRIB3', 'PPARG', 'IL6ST', 'PPARA']",0.9998978587529065,0,0,32
219,Cell cycle WP179,0.38186557114017344,1.0897960057366698,1.0491320553964993,"['RB1', 'GSK3B', 'CDKN1B', 'YWHAB', 'HDAC1', 'ANAPC10', 'ANAPC11', 'ORC5', 'CCND2', 'ORC6', 'CCND1', 'YWHAQ', 'CDC27', 'ORC2', 'ABL1', 'EP300', 'SKP2', 'SKP1', 'SMAD2', 'CDKN2D', 'TGFB1', 'GADD45A', 'CDC7', 'STAG1', 'CDK6', 'STAG2', 'RBL1', 'CCNE2', 'TFDP2', 'MCM4', 'ATM', 'MCM6']",0.9998978587529065,0,0,32
220,PDGF Pathway WP2526,0.3821757453411652,1.1685982184716361,1.1240450723066904,"['MAP2K4', 'MAP3K1', 'STAT1', 'NFKB1', 'CDC42', 'TIAM1', 'MAPK8', 'RASA1', 'ARFIP2', 'MAPK1', 'RAC1', 'SOS1', 'HRAS']",0.9998978587529065,0,0,13
221,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.3826104116982642,1.1025912896113288,1.0593013606908395,"['GSK3B', 'PIK3R3', 'PIK3CB', 'EGFR', 'IGF1R', 'CCND1', 'PDGFD', 'AKT3', 'PDGFC', 'MAPK1', 'JAK2', 'HRAS', 'RPS6', 'GAB1', 'PRKCA', 'BRAF', 'NRG2', 'MRAS', 'PIK3CA', 'RPS6KB1', 'NF1', 'BAX', 'EIF4E2', 'SOS1', 'SOS2', 'FGFR2']",0.9998978587529065,0,0,26
222,Acute viral myocarditis WP4298,0.3869265884762413,1.1237089201877934,1.0669844285443686,"['GSK3B', 'ENDOG', 'TGFB1', 'STAT1', 'ILK', 'SGCD', 'CREB1', 'CCND1', 'RASA1', 'ABL1', 'MAPK1', 'ABL2', 'CYCS', 'BAX', 'FYN', 'SOS1', 'TLR4', 'EIF4G2', 'EIF4G1']",0.9998978587529065,0,0,19
223,IL-2 signaling pathway WP49,0.39398954657451923,1.177098674521355,1.0963860796497193,"['STAT5B', 'CCND2', 'RPS6KB1', 'STAT1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'CBL', 'SOS1', 'HRAS']",0.9998978587529065,0,0,11
224,Mesodermal commitment pathway WP2857,0.39834514690394496,1.076308498813849,0.9906735696899485,"['MACF1', 'SETD2', 'BMPR2', 'ACACA', 'SOX2', 'MBTD1', 'CCND1', 'SESN1', 'UBR5', 'RPL38', 'ASCC3', 'PRKACA', 'JAK2', 'JARID2', 'TEAD1', 'SMAD2', 'VAV3', 'PBX3', 'ARID5B', 'TRERF1', 'EMSY', 'PIAS1', 'EXT1', 'LATS1', 'CCDC88A', 'TOX3', 'DDAH1', 'PRKAR1A', 'NABP2', 'RARB', 'TCF4', 'WDFY2', 'TOX', 'BMPR1A']",0.9998978587529065,0,0,34
225,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4042809164730106,1.1236218625381187,1.0176028642365165,"['VAV3', 'HELLS', 'BEX3', 'CDKN1B', 'HSPA5', 'HDAC1', 'RNF7', 'PTK2', 'NFKB1', 'HSPD1', 'RPS6KB1', 'SERBP1', 'ABL1', 'MAPK1', 'APOE', 'SQSTM1']",0.9998978587529065,0,0,16
226,Interferon type I signaling pathways WP585,0.4042809164730106,1.1236218625381187,1.0176028642365165,"['MAP2K3', 'MAP3K1', 'STAT1', 'RPS6', 'GAB2', 'CBL', 'PIAS1', 'RPTOR', 'CREB1', 'RAP1A', 'RPS6KB1', 'RACK1', 'FYN', 'RAC1', 'EIF4B', 'IFNAR1']",0.9998978587529065,0,0,16
227,Pathogenic Escherichia coli infection WP2272,0.4042809164730106,1.1236218625381187,1.0176028642365165,"['ROCK1', 'ROCK2', 'PRKCA', 'ARPC5', 'CLDN1', 'ACTG1', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC3', 'NCK2', 'ABL1', 'FYN', 'ARHGEF2', 'TLR4']",0.9998978587529065,0,0,16
228,Integrin-mediated Cell Adhesion WP185,0.40650033242597394,1.0835741163822068,0.9754014890419972,"['ROCK1', 'ROCK2', 'PXN', 'ILK', 'ITGAE', 'CDC42', 'RAP1A', 'AKT3', 'CAPN3', 'MAPK1', 'FYN', 'RAC1', 'PAK3', 'MAPK6', 'HRAS', 'TNS1', 'MAP2K3', 'VAV3', 'BRAF', 'PTK2', 'MAPK10', 'ITGA10', 'SELENOP', 'ITGA8', 'SOS1', 'ARHGEF7', 'VCL']",0.9998978587529065,0,0,27
229,Nanoparticle-mediated activation of receptor signaling WP2643,0.4073470990724064,1.1896266703402671,1.0683913806210605,"['MAPK10', 'MAPK8', 'PXN', 'AKT3', 'MAPK1', 'SOS1', 'HRAS', 'EGFR', 'PTK2']",0.9998978587529065,0,0,9
230,Resistin as a regulator of inflammation WP4481,0.4073470990724064,1.1896266703402671,1.0683913806210605,"['PLCB4', 'PIK3CA', 'AKT3', 'ITPR1', 'MAPK1', 'PLCE1', 'PIK3CB', 'PLCB1', 'NFKB1']",0.9998978587529065,0,0,9
231,White fat cell differentiation WP4149,0.4073470990724064,1.1896266703402671,1.0683913806210605,"['WNT10B', 'TLE3', 'STAT5B', 'CREB1', 'DDIT3', 'RORA', 'PPARG', 'NR3C1', 'FOXO1']",0.9998978587529065,0,0,9
232,Cannabinoid receptor signaling WP3869,0.41480041493669395,1.198407867010068,1.0545483529104815,"['MAPK10', 'MAPK8', 'ADORA2A', 'PRKAR2B', 'PRKAR1A', 'MAPK1', 'AHR', 'PRKACA']",0.9998978587529065,0,0,8
233,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.41480041493669395,1.198407867010068,1.0545483529104815,"['LAMA5', 'CCND2', 'CCND1', 'FGF1', 'NFKB1', 'GTPBP4', 'RUNX2', 'FGFR2']",0.9998978587529065,0,0,8
234,Canonical and non-canonical Notch signaling WP3845,0.4229353138050498,1.2098998847594353,1.041162448460353,"['MFAP1', 'CNTN6', 'PSEN2', 'ADAM10', 'MAML3', 'DLL3', 'DLK2']",0.9998978587529065,0,0,7
235,Trans-sulfuration and one-carbon metabolism WP2525,0.4229353138050498,1.2098998847594353,1.041162448460353,"['AHCYL2', 'AHCY', 'GSS', 'DNMT3A', 'AMT', 'MAT2B', 'PSPH']",0.9998978587529065,0,0,7
236,TGF-beta Receptor Signaling WP560,0.4245528121370151,1.1235349273323958,0.9625535741949585,"['SMAD2', 'CREBBP', 'TGFB1', 'ZFYVE9', 'STAT1', 'RUNX2', 'NFKB1', 'TGFBR3', 'ZEB2', 'SPP1', 'EP300', 'HRAS', 'ENG']",0.9998978587529065,0,0,13
237,Regulation of toll-like receptor signaling pathway WP1449,0.4295988078197362,1.0664848550091903,0.9010767983030055,"['OTUD5', 'CUEDC2', 'PELI3', 'PELI2', 'PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'AKT3', 'TIFA', 'SPP1', 'MAPK1', 'FADD', 'RAC1', 'MAP3K7', 'MAP2K3', 'MAP2K4', 'TICAM2', 'STAT1', 'NFKB1', 'MAPK10', 'PIK3CA', 'TRAF3', 'TAB2', 'ZMYND11', 'SQSTM1', 'TLR4', 'IFNAR1']",0.9998978587529065,0,0,28
238,Mitochondrial Gene Expression WP391,0.4319472429172912,1.22558134587154,1.0288164926640717,"['PPP3CA', 'CREB1', 'CAMK4', 'TFAM', 'NRF1', 'PPARGC1A']",0.9998978587529065,0,0,6
239,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.4319472429172912,1.22558134587154,1.0288164926640717,"['ABCA1', 'ABCB1', 'ABCD3', 'RARB', 'PPARG', 'PPARA']",0.9998978587529065,0,0,6
240,Nucleotide metabolism WP404,0.4319472429172912,1.22558134587154,1.0288164926640717,"['PRPS1', 'POLA1', 'RRM2B', 'NME2', 'OAZ1', 'SRM']",0.9998978587529065,0,0,6
241,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.43357711743315075,1.052527766339021,0.8795823018206677,"['GSK3B', 'PRKAA1', 'THRA', 'PRKAG1', 'PIK3R3', 'CBLB', 'PIK3CB', 'CBL', 'FOXO1', 'RPTOR', 'RPS6KA6', 'MAPK8', 'SESN3', 'RPS6KA2', 'MAPK1', 'RICTOR', 'MAP3K9', 'MAP4K5', 'MAPK6', 'MAP3K7', 'HRAS', 'MAP3K4', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K3', 'MAP2K4', 'ABCG8', 'MAP3K1', 'INSR', 'MAPK10', 'MLXIPL', 'PIK3CA', 'RPS6KB1', 'MAP3K10', 'SOS1', 'SOS2']",0.9998978587529065,0,0,37
242,PI3K-Akt signaling pathway WP4172,0.43377320041500106,1.033041114910525,0.8628305059304274,"['GSK3B', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'PIK3CB', 'LAMC1', 'FGF1', 'IGF1R', 'RPTOR', 'GHR', 'CCND2', 'CCND1', 'PPP2R5E', 'AKT3', 'RAC1', 'JAK2', 'HRAS', 'HSP90AA1', 'RPS6', 'PPP2R5B', 'PRKCA', 'PPP2R5C', 'CREB3', 'CREB1', 'COL4A2', 'CCNE2', 'PIK3CA', 'CDC37', 'ITGA8', 'SGK1', 'EIF4E2', 'SOS1', 'TLR4', 'SOS2', 'ATF4', 'IFNAR1', 'LAMA5', 'PRKAA1', 'PHLPP1', 'LPAR1', 'PIK3R3', 'EFNA5', 'EGFR', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PDGFD', 'PDGFC', 'SPP1', 'MAPK1', 'EIF4B', 'NTRK2', 'ANGPT1', 'LAMB2', 'INSR', 'VEGFD', 'PTK2', 'NFKB1', 'EPOR', 'EFNA3', 'CDK6', 'FGF14', 'RPS6KB1', 'PPP2R2B', 'ITGA10', 'GNB1', 'PPP2R2D', 'PKN2', 'GNB5', 'FGF12', 'FGFR2']",0.9998978587529065,0,0,74
243,Pathways Regulating Hippo Signaling WP4540,0.4414213653727921,1.0622747579248872,0.8686809011750998,"['PRKAA1', 'PRKAG1', 'GNAI3', 'EGFR', 'IGF1R', 'CDC42', 'CDH2', 'PRKAR2B', 'PRKAR2A', 'RAC1', 'PRKACA', 'TEAD1', 'SMAD2', 'NTRK2', 'PRKCE', 'INSR', 'PRKCA', 'LATS1', 'GNAL', 'PLCB4', 'PRKAR1A', 'GNAQ', 'NF2', 'PLCB1', 'FGFR2', 'CDH18']",0.9998978587529065,0,0,26
244,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.44214104242408253,1.2482452035563874,1.0187257985122251,"['SMAD2', 'TGFB1', 'CDH2', 'MAPK1', 'RUNX2']",0.9998978587529065,0,0,5
245,Alpha 6 Beta 4 signaling pathway WP244,0.44928376402965625,1.1234481143124853,0.8988715099986784,"['LAMA5', 'LAMB2', 'GAB1', 'MAPK1', 'PRKCA', 'LAMC1', 'RAC1', 'SOS1', 'HRAS', 'PTK2']",0.9998978587529065,0,0,10
246,BDNF-TrkB Signaling WP3676,0.44928376402965625,1.1234481143124853,0.8988715099986784,"['NTRK2', 'CREB1', 'RPS6KB1', 'MKNK1', 'GAB1', 'MAPK1', 'BRAF', 'GAB2', 'SOS1', 'HRAS']",0.9998978587529065,0,0,10
247,MAPK Signaling Pathway WP382,0.45191124890715223,1.0286803879756947,0.8170494269732651,"['FGF1', 'DUSP16', 'PPP3CA', 'PPP3CC', 'STMN1', 'AKT3', 'RAC1', 'PRKACA', 'HRAS', 'MAP3K7', 'MAP3K4', 'MAP3K5', 'MAP2K3', 'MAP2K4', 'MEF2C', 'DUSP3', 'PLA2G4C', 'CACNA2D2', 'PRKCA', 'CACNB2', 'PPM1B', 'MRAS', 'CACNB4', 'DDIT3', 'RASA1', 'RASA2', 'RAPGEF2', 'SOS1', 'SOS2', 'ATF4', 'CACNA1B', 'CACNA1C', 'RASGRP2', 'RASGRP1', 'EGFR', 'CDC42', 'CACNA1I', 'CACNG7', 'MAPK8', 'PPP3R2', 'RAP1A', 'MKNK1', 'MAPK1', 'FLNB', 'FLNC', 'CACNG2', 'MAP4K3', 'MAP4K4', 'HSPA8', 'NTRK2', 'MAP3K1', 'TGFB1', 'GADD45A', 'BRAF', 'HSPA2', 'NFKB1', 'MAPK10', 'FGF14', 'TAOK3', 'TAOK1', 'NF1', 'TAB2', 'FGF12', 'PTPN5', 'FGFR2']",0.9998978587529065,0,0,65
248,Homologous recombination WP186,0.4540348944435084,1.283876357560568,1.013724665721795,"['POLD4', 'MRE11', 'POLD2', 'ATM']",0.9998978587529065,0,0,4
249,"NAD metabolism, sirtuins and aging WP3630",0.4540348944435084,1.283876357560568,1.013724665721795,"['TFAM', 'PPARG', 'NFKB1', 'FOXO1']",0.9998978587529065,0,0,4
250,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4581693776767795,1.0847071188907305,0.8466316336405642,"['SMAD2', 'CREBBP', 'TGFB1', 'ZFYVE9', 'STAT1', 'RUNX2', 'NFKB1', 'TGFBR3', 'ZEB2', 'SPP1', 'EP300', 'HRAS', 'ENG', 'FBN1']",0.9998978587529065,0,0,14
251,Cell Differentiation - Index WP2029,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['MEF2A', 'MEF2C', 'MEF2D']",0.9998978587529065,0,0,3
252,"Degradation pathway of sphingolipids, including diseases WP4153",0.46862782738648623,1.3480355472404115,1.0217386504403598,"['NEU3', 'GLB1', 'NEU1']",0.9998978587529065,0,0,3
253,Heme Biosynthesis WP561,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['ALAD', 'UROD', 'UROS']",0.9998978587529065,0,0,3
254,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['UBA3', 'ELOB', 'ELOC']",0.9998978587529065,0,0,3
255,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.46862782738648623,1.3480355472404115,1.0217386504403598,"['ABCA1', 'APOA1', 'APOE']",0.9998978587529065,0,0,3
256,NLR Proteins WP288,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['MAPK8', 'ERBIN', 'MAP3K7']",0.9998978587529065,0,0,3
257,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['NKRF', 'HLA-DRA', 'FYN']",0.9998978587529065,0,0,3
258,Trans-sulfuration pathway WP2333,0.46862782738648623,1.3480355472404115,1.0217386504403598,"['AHCY', 'GOT1', 'MAT2B']",0.9998978587529065,0,0,3
259,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.46974985322316737,1.1233903067197377,0.8487831105582403,"['RAB3B', 'FGD4', 'RAB3A', 'MPZ', 'MFN2', 'SBF2', 'RAB11A', 'DNM2']",0.9998978587529065,0,0,8
260,Senescence and Autophagy in Cancer WP615,0.47776954119092685,1.040197461212976,0.7683177160619651,"['RB1', 'GSK3B', 'CDKN1B', 'AMBRA1', 'CXCL14', 'GABARAP', 'IGF1R', 'MAP1LC3B', 'MAP1LC3A', 'MAPK1', 'SLC39A1', 'HRAS', 'SLC39A3', 'MAP2K3', 'GABARAPL2', 'GABARAPL1', 'TGFB1', 'IGFBP3', 'ATG10', 'BRAF', 'RSL1D1', 'BMP2', 'IRF1', 'IL6ST', 'SQSTM1']",0.9998978587529065,0,0,25
261,Insulin Signaling WP481,0.4799039872899604,1.0233268543013054,0.7512950800314199,"['GSK3B', 'ARF1', 'PRKAA1', 'STXBP4', 'STXBP1', 'PIK3R3', 'CBLB', 'PIK3CB', 'CBL', 'FOXO1', 'IGF1R', 'CYTH3', 'RPS6KA6', 'MAPK8', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'RAC1', 'MAP4K5', 'MAPK6', 'MAP3K7', 'GYG1', 'HRAS', 'MAP3K4', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K3', 'MAP2K4', 'XBP1', 'MAP3K1', 'INSR', 'GAB1', 'PRKCA', 'INPP4A', 'MAPK10', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'MAP3K10', 'TRIB3', 'SOS1', 'SGK1', 'SOS2', 'PFKM', 'ARF6']",0.9998978587529065,0,0,46
262,Fatty Acid Biosynthesis WP357,0.48183198197706417,1.1233614232209739,0.82023336425171,"['ACLY', 'MECR', 'ECHS1', 'PC', 'ACSL4', 'ACACB', 'ACACA']",0.9998978587529065,0,0,7
263,IL-7 signaling pathway WP205,0.48183198197706417,1.1233614232209739,0.82023336425171,"['GSK3B', 'STAT5B', 'CDKN1B', 'CCND1', 'STAT1', 'MAPK1', 'FYN']",0.9998978587529065,0,0,7
264,Unfolded protein response WP4925,0.48183198197706417,1.1233614232209739,0.82023336425171,"['XBP1', 'HSPA5', 'DDIT3', 'RTCB', 'ATF6', 'BBC3', 'ATF4']",0.9998978587529065,0,0,7
265,Hippo-Merlin Signaling Dysregulation WP4541,0.4864233394894668,1.0313021815503391,0.7432346952394688,"['ITGAE', 'EGFR', 'IGF1R', 'DCAF1', 'PPP1CC', 'CCND1', 'CDH2', 'PRKAR2B', 'PRKAR2A', 'PRKACA', 'PAK3', 'HRAS', 'TEAD1', 'PAK5', 'NTRK2', 'PPP1R14A', 'PPP1R12A', 'INSR', 'PTK2', 'LATS1', 'DDB1', 'PLCB4', 'PRKAR1A', 'ITGA10', 'ITGA8', 'NF2', 'FGFR2', 'CDH18']",0.9998978587529065,0,0,28
266,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.48647573804144073,1.0745181532944867,0.7742636642575317,"['MAP2K3', 'MAPK10', 'MAP2K4', 'MAPK8', 'MAP3K1', 'RPS6KA2', 'DDIT3', 'MAPK1', 'MAP3K10', 'MAP3K9', 'MAP3K4']",0.9998978587529065,0,0,11
267,IL-18 signaling pathway WP4754,0.48772748958201434,1.0164106381538878,0.7297812648851991,"['GSK3B', 'PIGT', 'CD83', 'CD81', 'RND2', 'CLDN1', 'RPTOR', 'TMSB4X', 'STMN1', 'NFKBIZ', 'B2M', 'MAP3K7', 'MEF2A', 'TICAM2', 'USP5', 'IMP3', 'FBXW7', 'PRKCA', 'NDUFC1', 'BPGM', 'RUNX2', 'ARFGAP2', 'ARL4D', 'ALS2', 'IRF1', 'RFX5', 'KIFC3', 'LTB', 'ARF6', 'PRKAA1', 'TOMM40', 'EPB41', 'RGS16', 'COX17', 'ACACB', 'CENPB', 'SPP1', 'MAPK1', 'TRPM7', 'FADD', 'ABCF1', 'ZNF143', 'HPS1', 'CFLAR', 'GRIN2B', 'NFKB1', 'SLC4A7', 'BMP2', 'RPS6KB1', 'NACA', 'SYT10', 'ZNF219', 'CYCS', 'BAX', 'NFKBIE', 'AARS', 'ITM2C']",0.9998978587529065,0,0,57
268,EV release from cardiac cells and their functional effects WP3297,0.4882788793592061,1.497778816927753,1.0737105470765687,"['ERBB4', 'RGS16']",0.9998978587529065,0,0,2
269,FOXP3 in COVID-19 WP5063,0.4882788793592061,1.497778816927753,1.0737105470765687,"['STAT5B', 'IL6ST']",0.9998978587529065,0,0,2
270,Metastatic brain tumor WP2249,0.4882788793592061,1.497778816927753,1.0737105470765687,"['CDC42', 'CDK6']",0.9998978587529065,0,0,2
271,miR-517 relationship with ARCN1 and USP1 WP3596,0.4882788793592061,1.497778816927753,1.0737105470765687,"['USP1', 'ARCN1']",0.9998978587529065,0,0,2
272,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.4882788793592061,1.497778816927753,1.0737105470765687,"['FOXO1', 'IGF1R']",0.9998978587529065,0,0,2
273,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.4882788793592061,1.497778816927753,1.0737105470765687,"['MAPK1', 'EGFR']",0.9998978587529065,0,0,2
274,Tgif disruption of Shh signaling WP3674,0.4882788793592061,1.497778816927753,1.0737105470765687,"['SMAD2', 'GLI3']",0.9998978587529065,0,0,2
275,The alternative pathway of fetal androgen synthesis WP4524,0.4882788793592061,1.497778816927753,1.0737105470765687,"['STAR', 'HSD17B6']",0.9998978587529065,0,0,2
276,Purine metabolism and related disorders WP4224,0.4956919940211314,1.1233325532412826,0.7883553755481878,"['PRPS1', 'GRM5', 'RRM2B', 'PFAS', 'ITPA', 'APRT']",0.9998978587529065,0,0,6
277,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.4956919940211314,1.1233325532412826,0.7883553755481878,"['TBK1', 'STAT1', 'TRAF3', 'EIF2AK2', 'TLR4', 'IFNAR1']",0.9998978587529065,0,0,6
278,MAPK Cascade WP422,0.4975683134632697,1.0698390389184487,0.746771633154844,"['MAP2K3', 'MAPK10', 'MAP2K4', 'MAP3K1', 'MAP2', 'MAPK1', 'BRAF', 'SOS1', 'HRAS', 'SOS2']",0.9998978587529065,0,0,10
279,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5082393530557677,1.0322206298273873,0.6986097866129096,"['GSK3B', 'ACTR2', 'MAP2K4', 'CDKN1B', 'ROCK2', 'CBL', 'EGFR', 'PTK2', 'SOD1', 'MAPK8', 'APC', 'ERBB4', 'TMSB4X', 'PFN4', 'MAPK1', 'SOS1', 'PFN2']",0.9998978587529065,0,0,17
280,Oncostatin M Signaling Pathway WP2374,0.5082393530557677,1.0322206298273873,0.6986097866129096,"['STAT5B', 'CDKN1B', 'STAT1', 'PRKCE', 'RPS6', 'PXN', 'PRKCA', 'LIFR', 'NFKB1', 'MAPK8', 'CREB1', 'MAPK1', 'RICTOR', 'JAK2', 'IL6ST', 'SOS1', 'HRAS']",0.9998978587529065,0,0,17
281,MAPK pathway in congenital thyroid cancer WP4928,0.5120470556641942,1.1233036967711745,0.7518706951558403,"['ALK', 'KSR1', 'BRAF', 'SOS1', 'SOS2']",0.9998978587529065,0,0,5
282,Aflatoxin B1 metabolism WP699,0.5212079353014867,2.2466105656848994,1.463905393326609,['AKR7A2'],0.9998978587529065,0,0,1
283,Arylamine metabolism WP694,0.5212079353014867,2.2466105656848994,1.463905393326609,['SULT1A1'],0.9998978587529065,0,0,1
284,Glycosylation and related congenital defects WP4521,0.5234324216032501,1.0571983417576818,0.6843745413534528,"['DPM2', 'DPM3', 'TUSC3', 'MPI', 'ALG14', 'ALG3', 'MAGT1', 'ALG11']",0.9998978587529065,0,0,8
285,Sphingolipid pathway WP1422,0.5234324216032501,1.0571983417576818,0.6843745413534528,"['ASAH1', 'SGPL1', 'CERS5', 'CERS6', 'SGMS1', 'SERINC1', 'SGPP2', 'PLPP1']",0.9998978587529065,0,0,8
286,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.5315446118511947,1.0085956863365502,0.6374003489556683,"['MAP2K3', 'GSK3B', 'MAP2K4', 'CAMK2D', 'TGFB1', 'ROCK1', 'ROCK2', 'PIK3R3', 'PIK3CB', 'MYLK3', 'NFKB1', 'IGF1R', 'LRP6', 'PPP3CA', 'MAPK8', 'PIK3CA', 'MAPK1', 'RAC1', 'IL6ST', 'CALM1', 'PRKG1', 'FGFR2']",0.9998978587529065,0,0,22
287,Biomarkers for pyrimidine metabolism disorders WP4584,0.5321526762508945,1.1232748538011696,0.7085896859671553,"['RRM2B', 'DPYD', 'TK2', 'DHODH']",0.9998978587529065,0,0,4
288,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5321526762508945,1.1232748538011696,0.7085896859671553,"['SFRP1', 'BMP2', 'SST', 'FOXO1']",0.9998978587529065,0,0,4
289,FOXA2 pathway WP5066,0.5321526762508945,1.1232748538011696,0.7085896859671553,"['MLXIPL', 'ACACA', 'FOXO1', 'SLC27A5']",0.9998978587529065,0,0,4
290,Galanin receptor pathway WP4970,0.5321526762508945,1.1232748538011696,0.7085896859671553,"['CDKN1B', 'CREB1', 'PPARG', 'PPARGC1A']",0.9998978587529065,0,0,4
291,Hedgehog Signaling Pathway Netpath WP47,0.5321526762508945,1.1232748538011696,0.7085896859671553,"['STK36', 'SUFU', 'SAP18', 'GLI3']",0.9998978587529065,0,0,4
292,Prader-Willi and Angelman Syndrome WP3998,0.5383308635574411,1.0145142381726733,0.6282703251033503,"['RB1', 'CYFIP1', 'SLC45A2', 'GABRG3', 'GABRR2', 'HERC2', 'CCND2', 'CDK6', 'CCND1', 'FEZ1', 'NDN', 'MKRN3', 'GNRH1', 'BBS4']",0.9998978587529065,0,0,14
293,Estrogen signaling pathway WP712,0.5388908335792376,1.0483614232209737,0.6481413394569845,"['CREB1', 'PIK3CA', 'GNB1', 'MAPK1', 'BRAF', 'PRKACA', 'NFKB1']",0.9998978587529065,0,0,7
294,MTHFR deficiency WP4288,0.5388908335792376,1.0483614232209737,0.6481413394569845,"['GRIN2A', 'SGMS1', 'CHDH', 'DNMT3A', 'EHMT1', 'CYCS', 'HNMT']",0.9998978587529065,0,0,7
295,Focal Adhesion WP306,0.5440590147713785,0.9938749929375132,0.6049692781512943,"['GSK3B', 'ILK', 'PIK3CB', 'LAMC1', 'ARHGAP35', 'MYLK3', 'ACTG1', 'IGF1R', 'PPP1CC', 'CCND2', 'CCND1', 'AKT3', 'RAC1', 'HRAS', 'VAV3', 'PPP1R12A', 'PRKCA', 'HCK', 'COL4A2', 'PIK3CA', 'ITGA8', 'PPP1R12B', 'SOS1', 'VCL', 'LAMA5', 'ROCK1', 'ROCK2', 'PXN', 'PIK3R3', 'EGFR', 'MYL12B', 'CDC42', 'MAPK8', 'RELN', 'RAP1A', 'PDGFD', 'PDGFC', 'SPP1', 'MAPK1', 'FLNB', 'FYN', 'FLNC', 'PAK3', 'LAMB2', 'PARVA', 'BRAF', 'VEGFD', 'PTK2', 'MAPK10', 'ITGA10']",0.9998978587529065,0,0,50
296,AGE/RAGE pathway WP2324,0.5440851631100452,1.004951962261355,0.6116635038715748,"['SMAD2', 'STAT5B', 'ROCK1', 'STAT1', 'INSR', 'PRKCA', 'DDOST', 'FOXO1', 'EGFR', 'NFKB1', 'SOD1', 'CDC42', 'MAPK8', 'MAPK1', 'CYCS', 'RAC1', 'JAK2']",0.9998978587529065,0,0,17
297,Development of ureteric collection system WP5053,0.5446495474827848,1.0211035158329607,0.6204354880207636,"['GRIP1', 'FRAS1', 'CCND1', 'ITGA8', 'ILK', 'RARB', 'SLIT2', 'ETV4', 'GLI3', 'FGFR2']",0.9998978587529065,0,0,10
298,Ectoderm Differentiation WP2858,0.5449154967752209,0.9951651773464251,0.604189208610413,"['NLGN1', 'CTNND2', 'ARX', 'HMGB2', 'LDB2', 'CELSR2', 'GLI3', 'WDR44', 'SOX2', 'SOCS2', 'TRPM2', 'NARS2', 'ST8SIA4', 'FYN', 'ANKS1B', 'CDON', 'BCAS3', 'ELOVL4', 'SMURF1', 'C1GALT1', 'PTPN13', 'AHI1', 'TOX3', 'PTPRB', 'PLCXD3', 'MAFB', 'GLB1', 'ZNF219', 'NF2', 'KIFC3', 'PDE7A', 'FGFR2', 'TRIM33', 'ASTN1', 'BMPR1A']",0.9998978587529065,0,0,35
299,Eukaryotic Transcription Initiation WP405,0.549758039369212,1.0069919330067736,0.6024601388572213,"['GTF2A2', 'TAF13', 'ILK', 'GTF2H3', 'POLR2C', 'POLR2E', 'POLR1E', 'TAF7', 'POLR2G', 'POLR2I', 'MNAT1', 'POLR3K', 'POLR2K']",0.9998978587529065,0,0,13
300,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5567685304662345,1.036814344092603,0.60716437949697,"['H3F3B', 'H2AFY', 'H2AFJ', 'H2AFZ', 'EED', 'MAPK1']",0.9998978587529065,0,0,6
301,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.5567685304662345,1.036814344092603,0.60716437949697,"['CREBBP', 'DNMT3A', 'EP300', 'ATM', 'ZFX', 'ETV6']",0.9998978587529065,0,0,6
302,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5567685304662345,1.036814344092603,0.60716437949697,"['B3GALNT1', 'SGPL1', 'GALNT16', 'GALNT1', 'ST6GALNAC3', 'SGPP2']",0.9998978587529065,0,0,6
303,Farnesoid X receptor pathway WP2879,0.5584965687630468,1.123246024321796,0.654298451909571,"['PPARGC1A', 'SLC27A5', 'FKBP5']",0.9998978587529065,0,0,3
304,Purine metabolism WP4792,0.5584965687630468,1.123246024321796,0.654298451909571,"['PRPS1', 'ITPA', 'APRT']",0.9998978587529065,0,0,3
305,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5590005696114195,1.0108665105386416,0.5879248013902679,"['PPP3CA', 'CREBBP', 'PPP3CC', 'PPP3R2', 'HDAC1', 'SUPT4H1', 'EP300', 'SUPT5H', 'NFKB1']",0.9998978587529065,0,0,9
306,Nuclear receptors WP170,0.5590005696114195,1.0108665105386416,0.5879248013902679,"['THRA', 'RARB', 'RORA', 'ROR1', 'PPARG', 'NR2C2', 'NR3C1', 'PPARA', 'NR2F6']",0.9998978587529065,0,0,9
307,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5609787770570837,0.9870266426615428,0.5705726674533889,"['GSK3B', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'CAB39L', 'SLC2A3', 'PIK3CB', 'ITGAE', 'LAMC1', 'FGF1', 'IGF1R', 'RPTOR', 'GHR', 'PPP2R5E', 'AKT3', 'JAK2', 'HRAS', 'HSP90AA1', 'RPS6', 'PPP2R5B', 'PPP2R5C', 'CREB3', 'CREB1', 'COL4A2', 'PIK3CA', 'CDC37', 'ITGA8', 'EIF4E2', 'SOS1', 'ATF4', 'IFNAR1', 'LAMA5', 'PRKAA1', 'PHLPP1', 'LPAR1', 'EFNA5', 'EGFR', 'FOXO1', 'ACACA', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PDGFD', 'PDGFC', 'SPP1', 'MAPK1', 'PPARGC1A', 'EIF4B', 'ANGPT1', 'LAMB2', 'INSR', 'VEGFD', 'PTK2', 'EPOR', 'RAB10', 'EFNA3', 'FGF14', 'RAB14', 'PIK3IP1', 'RPS6KB1', 'PPP2R2B', 'ITGA10', 'GNB1', 'PPP2R2D', 'FGF12', 'FGFR2']",0.9998978587529065,0,0,69
308,Cardiac Progenitor Differentiation WP2406,0.5750258683185174,0.9983610395691875,0.5524333480408387,"['SOX2', 'MESP1', 'GSK3B', 'MEF2C', 'TGFB1', 'BMP1', 'THY1', 'MYLK3']",0.9998978587529065,0,0,8
309,Endothelin Pathways WP2197,0.5750258683185174,0.9983610395691875,0.5524333480408387,"['NPY1R', 'RIIAD1', 'ATP2A2', 'MAPK1', 'PRKCA', 'GNB5', 'PLCB1', 'CALM1']",0.9998978587529065,0,0,8
310,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5780115870891255,1.0210788275832732,0.5597159625157536,"['MAP2K3', 'PRKAA1', 'MKNK1', 'MAPK1', 'MAP3K5']",0.9998978587529065,0,0,5
311,Globo Sphingolipid Metabolism WP1424,0.5780115870891255,1.0210788275832732,0.5597159625157536,"['B3GALNT1', 'ST8SIA1', 'ST6GALNAC3', 'ST6GALNAC4', 'ST6GALNAC5']",0.9998978587529065,0,0,5
312,"GPCRs, Class B Secretin-like WP334",0.5780115870891255,1.0210788275832732,0.5597159625157536,"['ADCYAP1R1', 'ADGRG2', 'ADGRE5', 'ADGRL2', 'ADGRL3']",0.9998978587529065,0,0,5
313,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5780115870891255,1.0210788275832732,0.5597159625157536,"['BMP2', 'TGFB1', 'CDC37', 'NRF1', 'PKD1']",0.9998978587529065,0,0,5
314,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5780115870891255,1.0210788275832732,0.5597159625157536,"['NLRX1', 'TBK1', 'ITPR1', 'NFKBIE', 'NFKB1']",0.9998978587529065,0,0,5
315,Target Of Rapamycin (TOR) Signaling WP1471,0.5899765144824034,0.9766058643201239,0.515328105634647,"['RPTOR', 'CDC42', 'IDI1', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'PRKAG1', 'RICTOR', 'PRKCA', 'RAC1']",0.9998978587529065,0,0,10
316,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5899765144824034,0.9766058643201239,0.515328105634647,"['GSK3B', 'MAPK8', 'HDAC1', 'TRAF3', 'MAPK1', 'FADD', 'RAC1', 'MAP3K7', 'NFKB1', 'NFKBIB']",0.9998978587529065,0,0,10
317,Type 2 papillary renal cell carcinoma WP4241,0.5899765144824034,0.9766058643201239,0.515328105634647,"['EGLN1', 'SETD2', 'CREBBP', 'TGFB1', 'CADM2', 'TFEB', 'EP300', 'ARNT', 'ELOB', 'ELOC']",0.9998978587529065,0,0,10
318,Apoptosis WP254,0.591399898714366,0.9698676909944516,0.5094354605387267,"['HRK', 'HELLS', 'MAP2K4', 'MAP3K1', 'CRADD', 'TRADD', 'CFLAR', 'NFKB1', 'IGF1R', 'BBC3', 'MAPK10', 'TRAF3', 'IRF1', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2', 'NFKBIB']",0.9998978587529065,0,0,19
319,Sphingolipid Metabolism (integrated pathway) WP4726,0.5931803574780411,0.9827364232209738,0.5132407620259357,"['ASAH1', 'SGPL1', 'CERS5', 'CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9998978587529065,0,0,7
320,Thermogenesis WP4321,0.5967882737224537,0.9674320974250402,0.49938155948494733,"['PRKAA1', 'SMARCD3', 'PRKAG1', 'ADCY8', 'ACTG1', 'ADCY5', 'RPTOR', 'RPS6KA6', 'RPS6KA2', 'PRKACA', 'PPARGC1A', 'HRAS', 'PRKG1', 'MAP3K5', 'MAP2K3', 'RPS6', 'ACSL4', 'CPT1B', 'ARID1B', 'CREB3', 'ADCY9', 'CREB1', 'RPS6KB1', 'ZNF516', 'PPARG', 'SOS1', 'SOS2', 'MGLL']",0.9998978587529065,0,0,28
321,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['APOE', 'TLR4']",0.9998978587529065,0,0,2
322,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['HSD11B1', 'STAR']",0.9998978587529065,0,0,2
323,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['TCF4', 'RUNX2']",0.9998978587529065,0,0,2
324,exRNA mechanism of action and biogenesis WP2805,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['DROSHA', 'DICER1']",0.9998978587529065,0,0,2
325,Irinotecan pathway WP229,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['CYP3A5', 'CES2']",0.9998978587529065,0,0,2
326,Methylation Pathways WP704,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['MAT2B', 'HNMT']",0.9998978587529065,0,0,2
327,Molybdenum cofactor (Moco) biosynthesis WP4507,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['MARC2', 'SUOX']",0.9998978587529065,0,0,2
328,Tamoxifen metabolism WP691,0.5970727596551212,1.1232172083235914,0.5792614200171942,"['SULT1A1', 'CYP3A5']",0.9998978587529065,0,0,2
329,Kit receptor signaling pathway WP304,0.6018202258188653,0.9625770570892522,0.4887932668072052,"['STAT5B', 'STAT1', 'RPS6', 'PRKCA', 'MITF', 'GAB2', 'CBL', 'MAPK8', 'RPS6KB1', 'EP300', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'HRAS']",0.9998978587529065,0,0,15
330,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6018202258188653,0.9625770570892522,0.4887932668072052,"['IFI27L2', 'CAMK2D', 'STAT1', 'PRKCE', 'PRKCA', 'ISG15', 'NFKB1', 'MAPK8', 'PLCB4', 'SP3', 'PLCE1', 'MAPK1', 'PLCB1', 'HRAS', 'TLR4']",0.9998978587529065,0,0,15
331,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6018202258188653,0.9625770570892522,0.4887932668072052,"['OTUD5', 'NLRX1', 'MAP3K1', 'TRADD', 'ISG15', 'NFKB1', 'MAPK10', 'MAPK8', 'TBK1', 'TKFC', 'TRAF3', 'TRIM25', 'FADD', 'MAP3K7', 'NFKBIB']",0.9998978587529065,0,0,15
332,p53 transcriptional gene network WP4963,0.6018202258188653,0.9625770570892522,0.4887932668072052,"['TIGAR', 'SIVA1', 'XRCC5', 'GADD45A', 'FANCC', 'ISG15', 'CX3CL1', 'BBC3', 'PIDD1', 'RRM2B', 'SESN1', 'SESN2', 'BAX', 'ERCC5', 'ACAD11']",0.9998978587529065,0,0,15
333,GPR40 Pathway WP3958,0.6042273298314778,0.9983625730994152,0.5029798344689507,"['PLCL1', 'PLCE1', 'PLCB1', 'PKD1']",0.9998978587529065,0,0,4
334,Pyrimidine metabolism and related diseases WP4225,0.6042273298314778,0.9983625730994152,0.5029798344689507,"['RRM2B', 'DPYD', 'TK2', 'DHODH']",0.9998978587529065,0,0,4
335,Folate Metabolism WP176,0.6060220282153169,0.9626296420207427,0.4821224127790003,"['ABCA1', 'SLC46A1', 'AHCY', 'GPX4', 'FLAD1', 'INSR', 'APOA1', 'NFKB1', 'SOD1']",0.9998978587529065,0,0,9
336,Glioblastoma signaling pathways WP2261,0.6129651336102906,0.9565319548872181,0.46817190898267036,"['RB1', 'MAP2K3', 'MAP2K4', 'CDKN1B', 'GAB1', 'PRKCA', 'BRAF', 'PIK3CB', 'CBL', 'FOXO1', 'EGFR', 'IGF1R', 'CCND2', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'NF1', 'EP300', 'MAPK1', 'ATM', 'HRAS', 'FGFR2']",0.9998978587529065,0,0,23
337,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6141255836254204,0.9626558791080204,0.4693484939955134,"['SESN3', 'EI24', 'SHISA5', 'BAX', 'ATM', 'BBC3']",0.9998978587529065,0,0,6
338,Zinc homeostasis WP3529,0.6141255836254204,0.9626558791080204,0.4693484939955134,"['SLC39A6', 'SLC39A11', 'SLC39A7', 'SLC39A12', 'SLC39A1', 'SLC39A3']",0.9998978587529065,0,0,6
339,Wnt Signaling Pathway WP363,0.6142623584971424,0.9528295854204413,0.4643454414941355,"['GSK3B', 'PRKCA', 'LRP6', 'MAPK8', 'CDK6', 'CCND1', 'APC', 'MAPK1', 'PPARG', 'ROR1', 'TCF4', 'RAC1', 'MAP3K7', 'CSNK1G1']",0.9998978587529065,0,0,14
340,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6173352620840133,0.9502379064234734,0.4583406292214129,"['TBK1', 'TGFB1', 'TRAF3', 'STAT1', 'TRADD', 'CXCL17', 'EP300', 'TRIM25', 'FADD', 'NFKB1', 'IFNAR1']",0.9998978587529065,0,0,11
341,Intraflagellar transport proteins binding to dynein WP4532,0.6238791884054266,0.9457171376110611,0.4461879625855706,"['DYNC2H1', 'DYNLT1', 'IFT140', 'WDR60', 'DYNLT3', 'WDR19', 'DYNLL2', 'DYNC1I1']",0.9998978587529065,0,0,8
342,Oxidation by Cytochrome P450 WP43,0.6238791884054266,0.9457171376110611,0.4461879625855706,"['CYB5B', 'CYB5R1', 'CYB5R3', 'CYP2U1', 'CYP4V2', 'CYP51A1', 'CYP3A5', 'CYP2C18']",0.9998978587529065,0,0,8
343,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6245923476370656,0.9543227326266196,0.4491578019565805,"['GSK3B', 'TUSC3', 'EIF5A2', 'WNT8A', 'PIK3R3', 'PIK3CB', 'NR2C2', 'CLDN1', 'PKD1', 'LRP6', 'DLL3', 'MAPK8', 'CDH2', 'AKT3', 'MAPK1', 'HRAS', 'MEF2D', 'MAP2K3', 'SMAD2', 'MAP2K4', 'WNT10B', 'TGFB1', 'EED', 'NUBPL', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'COL4A2', 'PIK3CA', 'CTDSP1', 'STRAP', 'SOS1', 'SOS2']",0.9998978587529065,0,0,34
344,Genes related to primary cilium development (based on CRISPR) WP4536,0.6317008635426025,0.9487899389748706,0.4358165197601492,"['C2CD3', 'ARL6', 'IFT172', 'ARL3', 'CEP120', 'TXNDC15', 'TTBK2', 'KIF3B', 'TCTN3', 'TTC21B', 'TMEM67', 'INPP5E', 'BBS9', 'CEP192', 'KIFAP3', 'IFT57', 'PIBF1', 'BBS4', 'DYNC2H1', 'DYNLT1', 'IFT140', 'WDR19', 'ARMC9', 'SCLT1', 'CPLANE1', 'RPGRIP1L', 'IFT88', 'TMEM17', 'WDR60', 'SASS6']",0.9998978587529065,0,0,30
345,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6331018090974536,0.9358163504333568,0.42778414511249635,"['RB1', 'MAP2K4', 'MAPK8', 'MAP3K1', 'FAF1', 'CYCS', 'FADD', 'CFLAR', 'MAP3K7', 'ACTG1']",0.9998978587529065,0,0,10
346,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6331018090974536,0.9358163504333568,0.42778414511249635,"['MAPK8', 'RAP1A', 'PIK3CA', 'RASA1', 'PXN', 'GAB1', 'MAPK1', 'SOS1', 'HRAS', 'PTK2']",0.9998978587529065,0,0,10
347,Endometrial cancer WP4155,0.634062030926953,0.9400675679363398,0.4283027639524301,"['GSK3B', 'GADD45A', 'ILK', 'PIK3R3', 'BRAF', 'PIK3CB', 'FGF1', 'EGFR', 'CCND1', 'PIK3CA', 'APC', 'AKT3', 'MAPK1', 'BAX', 'SOS1', 'HRAS', 'SOS2', 'FGFR2']",0.9998978587529065,0,0,18
348,IL-1 signaling pathway WP195,0.636886724016072,0.9357410881801126,0.4221721931023904,"['MAP2K3', 'MAP2K4', 'MAP3K1', 'PELI2', 'HSPB2', 'IL1RAP', 'NFKB1', 'MAPK8', 'UBE2N', 'MAPK1', 'TAB2', 'UBE2V1', 'MAP3K7', 'SQSTM1', 'NFKBIB']",0.9998978587529065,0,0,15
349,Cancer immunotherapy by CTLA4 blockade WP4582,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['PIK3CA', 'PIK3R3', 'PIK3CB']",0.9998978587529065,0,0,3
350,Dopamine metabolism WP2436,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['PPP2CB', 'PRKACA', 'SOD1']",0.9998978587529065,0,0,3
351,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['CREB1', 'MAPK1', 'PTK2']",0.9998978587529065,0,0,3
352,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['PBX3', 'GPC6', 'TEAD1']",0.9998978587529065,0,0,3
353,Nanoparticle triggered regulated necrosis WP2513,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['MAPK8', 'TRADD', 'FADD']",0.9998978587529065,0,0,3
354,Neuroinflammation WP4919,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['MAPK8', 'ASCC1', 'TLR4']",0.9998978587529065,0,0,3
355,Non-homologous end joining WP438,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['XRCC6', 'DCLRE1C', 'XRCC5']",0.9998978587529065,0,0,3
356,Osteopontin Signaling WP1434,0.6384511955114981,0.9626820793799279,0.43196511684061306,"['SPP1', 'MAPK1', 'NFKB1']",0.9998978587529065,0,0,3
357,Apoptosis Modulation by HSP70 WP384,0.6388716834863802,0.9358914365933552,0.41932770527357555,"['MAPK10', 'MAP3K1', 'CYCS', 'FADD', 'NFKB1']",0.9998978587529065,0,0,5
358,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6388716834863802,0.9358914365933552,0.41932770527357555,"['RAB5C', 'MRAS', 'MAPK1', 'BRAF', 'HRAS']",0.9998978587529065,0,0,5
359,Nanomaterial induced apoptosis WP2507,0.6388716834863802,0.9358914365933552,0.41932770527357555,"['ENDOG', 'BAX', 'CYCS', 'CFLAR', 'FADD']",0.9998978587529065,0,0,5
360,Complement system WP2806,0.6417673024167997,0.9293131732704072,0.4121778054952857,"['LAMA5', 'RPS19', 'GNAI3', 'SPP1', 'APOA1', 'PRKCA', 'CD59', 'TXN', 'CALR', 'LAMC1', 'PRKACA', 'KLKB1']",0.9998978587529065,0,0,12
361,Apoptosis Modulation and Signaling WP1772,0.6428424966268632,0.9356656492134304,0.41342904654152884,"['HRK', 'TNFRSF6B', 'ENDOG', 'CRADD', 'TRADD', 'CFLAR', 'PTPN13', 'NFKB1', 'BBC3', 'PIDD1', 'MAPK8', 'TRAF3', 'MADD', 'CYCS', 'BAX', 'BIRC6', 'PRKD1', 'FADD', 'BCL2L2', 'MAP3K5']",0.9998978587529065,0,0,20
362,Gastric Cancer Network 2 WP2363,0.6440046450327047,0.9248320114562679,0.40697171636326845,"['OTUD5', 'AHCTF1', 'DSCC1', 'UBE2T', 'BRIX1', 'CEBPZ', 'EGFR']",0.9998978587529065,0,0,7
363,Integrated Cancer Pathway WP1971,0.6570902477197618,0.9149484536082474,0.3842178784456177,"['ATF1', 'RB1', 'SMAD2', 'MRE11', 'CDKN1B', 'POU2F1', 'STAT1', 'BAX', 'ATM', 'BBC3', 'MAP3K5']",0.9998978587529065,0,0,11
364,Male infertility WP4673,0.6660505433641035,0.9266064290752746,0.37656332761812794,"['SLC46A1', 'CCNT2', 'DDX4', 'ABCB1', 'CXXC1', 'AHR', 'CHD2', 'ABLIM1', 'EP300', 'SLC16A7', 'RGS9', 'SOX5', 'NANOS1', 'USP8', 'CREBBP', 'PACRG', 'UBE2B', 'XRCC5', 'INSR', 'PEX10', 'TEX15', 'CDC42BPA', 'PUM2', 'HLA-DRA', 'ATM', 'CLOCK']",0.9998978587529065,0,0,26
365,Microglia Pathogen Phagocytosis Pathway WP3937,0.6670429807517408,0.8983852094547157,0.36375688663347056,"['VAV3', 'HCK', 'PIK3CA', 'PIK3R3', 'PIK3CB', 'RAC1']",0.9998978587529065,0,0,6
366,TLR4 Signaling and Tolerance WP3851,0.6670429807517408,0.8983852094547157,0.36375688663347056,"['TBK1', 'TRAF3', 'TAB2', 'MAP3K7', 'TLR4', 'NFKB1']",0.9998978587529065,0,0,6
367,Toll-like Receptor Signaling related to MyD88 WP3858,0.6670429807517408,0.8983852094547157,0.36375688663347056,"['TBK1', 'TICAM2', 'TRAF3', 'MAPK1', 'TLR4', 'NFKB1']",0.9998978587529065,0,0,6
368,GABA metabolism (aka GHB) WP4157,0.6687165586603728,1.1231884057971016,0.4519653848071084,['AKR7A2'],0.9998978587529065,0,0,1
369,let-7 inhibition of ES cell reprogramming WP3299,0.6687165586603728,1.1231884057971016,0.4519653848071084,['SOX2'],0.9998978587529065,0,0,1
370,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.6687165586603728,1.1231884057971016,0.4519653848071084,['CHRM1'],0.9998978587529065,0,0,1
371,Steroid Biosynthesis WP496,0.6687165586603728,1.1231884057971016,0.4519653848071084,['HSD17B1'],0.9998978587529065,0,0,1
372,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6690617878054521,0.8984327485380117,0.36106113296039904,"['RPH3A', 'MADD', 'UNC13D', 'SYTL2']",0.9998978587529065,0,0,4
373,Riboflavin and CoQ disorders WP5037,0.6690617878054521,0.8984327485380117,0.36106113296039904,"['FLAD1', 'SLC52A2', 'SLC52A1', 'PDSS2']",0.9998978587529065,0,0,4
374,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6695137293276479,0.8983376258487473,0.36041629599534536,"['MAPK8', 'TBK1', 'STAT1', 'TRAF3', 'EIF2AK2', 'MAP3K7', 'NFKB1', 'IFNAR1']",0.9998978587529065,0,0,8
375,Integrated breast cancer pathway WP1984,0.6759660127032564,0.9313578883982336,0.3647313736253641,"['ATF1', 'RB1', 'USP15', 'MRE11', 'BMPR2', 'HDAC1', 'ZMYND8', 'NAB1', 'TRADD', 'ODC1', 'AHR', 'PHB', 'FOXO1', 'EGFR', 'CDC42', 'RAP1A', 'CCND1', 'RASGEF1A', 'ABL1', 'EP300', 'MAPK1', 'FADD', 'RAC1', 'RPP38', 'SMAD2', 'RALGAPA1', 'GADD45A', 'STAT1', 'NCOA3', 'BRAF', 'NFKB1', 'PIAS1', 'FER', 'CREB1', 'NF1', 'BAX', 'ATM', 'FAU', 'BMPR1A']",0.9998978587529065,0,0,39
376,Nuclear Receptors Meta-Pathway WP2882,0.6871736818771763,0.937641679170158,0.35177334726682435,"['CDKN1B', 'HSP90AB1', 'KEAP1', 'SLC2A3', 'AHR', 'SLC6A1', 'NR3C1', 'EPB41L4B', 'RGS2', 'CCND1', 'SLC39A6', 'ME1', 'EP300', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'NCOA1', 'NCOA2', 'ABCG8', 'HSP90AA1', 'NCOA6', 'NCOA3', 'SLC2A13', 'SLC39A11', 'AIP', 'ARNT', 'APOA1', 'SLC39A12', 'CES4A', 'TGFBR3', 'KAT2B', 'NAV3', 'ACOX1', 'CDC37', 'BLVRB', 'PPARA', 'SQSTM1', 'EPHA3', 'CES2', 'SLC27A5', 'FKBP5', 'ABCB1', 'MGST3', 'ABHD2', 'TXN', 'SLC5A3', 'CYP3A5', 'EGFR', 'FOXO1', 'SULT1A1', 'FGD4', 'PPARGC1A', 'TGFB1', 'PLK2', 'PTGES3', 'SMARCA1', 'SLC6A6', 'PSMC5', 'SLC6A9', 'MAFF', 'BAX']",0.9998978587529065,0,0,61
377,Dual hijack model of Vif in HIV infection WP3300,0.687411227263822,0.8984802431610942,0.3367706844006685,"['ELOB', 'ELOC']",0.9998978587529065,0,0,2
378,Estrogen metabolism WP697,0.687411227263822,0.8984802431610942,0.3367706844006685,"['SULT1A1', 'ARSD']",0.9998978587529065,0,0,2
379,LDLRAD4 and what we know about it WP4904,0.687411227263822,0.8984802431610942,0.3367706844006685,"['SMAD2', 'LDLRAD4']",0.9998978587529065,0,0,2
380,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.687411227263822,0.8984802431610942,0.3367706844006685,"['BAX', 'IL6ST']",0.9998978587529065,0,0,2
381,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6908938022657752,0.8733614232209738,0.3229421146447212,"['SMAD2', 'TGFBR3', 'TGFB1', 'APC', 'PROM1', 'HRAS', 'EGFR']",0.9998978587529065,0,0,7
382,Signal transduction through IL1R WP4496,0.6908938022657752,0.8733614232209738,0.3229421146447212,"['MAP2K3', 'MAPK8', 'TGFB1', 'MAP3K1', 'IL1RAP', 'MAP3K7', 'NFKB1']",0.9998978587529065,0,0,7
383,Vitamin D in inflammatory diseases WP4482,0.6939407437381958,0.8638097980634246,0.3156090679613387,"['MAP2K3', 'PPP3CA', 'MAP3K1', 'NR3C1', 'NFKB1']",0.9998978587529065,0,0,5
384,Alanine and aspartate metabolism WP106,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['PC', 'GOT1', 'GAD1']",0.9998978587529065,0,0,3
385,Cancer immunotherapy by PD-1 blockade WP4585,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['HLA-A', 'PDCD1LG2', 'NFKB1']",0.9998978587529065,0,0,3
386,Development and heterogeneity of the ILC family WP3893,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['RORA', 'AHR', 'TOX']",0.9998978587529065,0,0,3
387,Inflammatory Response Pathway WP453,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['LAMA5', 'LAMB2', 'LAMC1']",0.9998978587529065,0,0,3
388,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['MAP3K1', 'MAPK1', 'NFKB1']",0.9998978587529065,0,0,3
389,Serotonin and anxiety-related events WP3944,0.7076072366209705,0.8422591206735267,0.29130886862765165,"['PPP3CA', 'NLGN1', 'CRH']",0.9998978587529065,0,0,3
390,Nephrotic syndrome WP4758,0.7114814962483952,0.8636502874029227,0.2939916261366356,"['SCARB2', 'SMARCAL1', 'CUBN', 'ANLN', 'LAMB2', 'TTC21B', 'PDSS2', 'PLCE1', 'WDR73', 'CD2AP']",0.9998978587529065,0,0,10
391,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7114814962483952,0.8636502874029227,0.2939916261366356,"['GUCY1A2', 'CAMK2D', 'GRIN2A', 'GUCY1A1', 'CREB1', 'AKAP9', 'CYCS', 'CALM1', 'GRIN2B', 'NFKB1']",0.9998978587529065,0,0,10
392,Tumor suppressor activity of SMARCB1 WP4204,0.7116139422529216,0.8554704485399873,0.29104792550370834,"['RB1', 'SMARCD3', 'CDK6', 'H3F3B', 'EED', 'DPF2', 'ARID1B', 'GLI3']",0.9998978587529065,0,0,8
393,Signal Transduction of S1P Receptor WP26,0.7150999892785195,0.8421483735080739,0.28240005709416854,"['ASAH1', 'AKT3', 'GNAI3', 'MAPK1', 'MAPK6', 'PLCB1']",0.9998978587529065,0,0,6
394,Sphingolipid Metabolism (general overview) WP4725,0.7150999892785195,0.8421483735080739,0.28240005709416854,"['ASAH1', 'SGPL1', 'CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9998978587529065,0,0,6
395,22q11.2 copy number variation syndrome WP4657,0.7238164350651535,0.8907582779232991,0.28790862937509415,"['PRKN', 'EMC10', 'ZDHHC8', 'CLDN1', 'EGFR', 'CDC42', 'AIFM3', 'MRPL40', 'XPO1', 'HIRIP3', 'RELN', 'DROSHA', 'SHOC2', 'TNPO1', 'DGCR2', 'RANBP1', 'CBX5', 'TXNRD2', 'NCOR1', 'THAP7', 'LZTR1', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN']",0.9998978587529065,0,0,25
396,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.726157992780856,0.8166719829877724,0.2613249624776915,"['CCND1', 'CFLAR', 'NFKB1', 'BCL2L2']",0.9998978587529065,0,0,4
397,SARS coronavirus and innate immunity WP4912,0.726157992780856,0.8166719829877724,0.2613249624776915,"['TBK1', 'STAT1', 'TRAF3', 'IFNAR1']",0.9998978587529065,0,0,4
398,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.726157992780856,0.8166719829877724,0.2613249624776915,"['ABCA1', 'PRKAA1', 'PPARA', 'PPARGC1A']",0.9998978587529065,0,0,4
399,Amyotrophic lateral sclerosis (ALS) WP2447,0.7299368339060552,0.8420374707259953,0.26507110332014616,"['PPP3CA', 'CCS', 'TOMM40', 'PPP3CC', 'ALS2', 'BAX', 'RAC1', 'MAP3K5', 'SOD1']",0.9998978587529065,0,0,9
400,Parkinson's disease pathway WP2371,0.7299368339060552,0.8420374707259953,0.26507110332014616,"['PRKN', 'ATXN2', 'PINK1', 'CCNE2', 'SYT11', 'CYCS', 'UBE2L6', 'UBE2G1', 'UBE2G2']",0.9998978587529065,0,0,9
401,Pre-implantation embryo WP3527,0.7335819452402232,0.8273087916420264,0.25631347537515226,"['SOX2', 'DLX2', 'DDIT3', 'SOX11', 'ATP1A1', 'ZFP36L2', 'NR3C2']",0.9998978587529065,0,0,7
402,Corticotropin-releasing hormone signaling pathway WP2355,0.7399370245203293,0.8729450446218882,0.2629224911862035,"['GSK3B', 'NCOA2', 'HSP90AA1', 'TGFB1', 'PRKCA', 'BRAF', 'ACACA', 'PTK2', 'NFKB1', 'GRK3', 'MAPK8', 'CREB1', 'STAR', 'GNAQ', 'GNB1', 'CRH', 'MAPK1', 'TCF4', 'GNB5', 'TLR4', 'MAP3K5']",0.9998978587529065,0,0,21
403,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7429307656584816,0.8020255364663413,0.2383238296735784,"['GNAQ', 'ITPR1', 'MAPK1', 'RASGRP1', 'HRAS']",0.9998978587529065,0,0,5
404,Nucleotide Excision Repair WP4753,0.7451451841587842,0.8419264119990626,0.2476747138440748,"['POLE4', 'DDB1', 'POLD4', 'CETN2', 'RPA3', 'POLD2', 'POLE3', 'RAD23A', 'ERCC5', 'GTF2H3', 'MNAT1', 'GTF2H5']",0.9998978587529065,0,0,12
405,Notch Signaling Pathway Netpath WP61,0.7454107903388283,0.8494661132410253,0.24958997720774564,"['GSK3B', 'FBXW7', 'HDAC1', 'PSEN2', 'NFKB1', 'DLL3', 'ITCH', 'NCOR1', 'CCND1', 'NUMB', 'EP300', 'MAML3', 'JAK2', 'SKP1']",0.9998978587529065,0,0,14
406,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7466074788571283,0.8551992225461613,0.24990263546278854,"['STAT5B', 'ANGPT1', 'PXN', 'FOXO1', 'EGFR', 'PTK2', 'NFKB1', 'MAPK8', 'PIK3CA', 'RASA1', 'STMN1', 'MAPK1', 'BAX', 'RAC1', 'SOS1', 'HRAS']",0.9998978587529065,0,0,16
407,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7466074788571283,0.8551992225461613,0.24990263546278854,"['CREBBP', 'IFNGR2', 'LIFR', 'EGFR', 'GHR', 'RPTOR', 'PTPRD', 'MAPK10', 'MAPK8', 'STMN1', 'MAPK1', 'RICTOR', 'JAK2', 'IL6ST', 'MAPK6', 'IFNAR1']",0.9998978587529065,0,0,16
408,Base Excision Repair WP4752,0.7500109615218232,0.8165002873502054,0.23488056146196212,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'MPG', 'APEX1', 'POLD2', 'POLE3']",0.9998978587529065,0,0,8
409,Retinoblastoma gene in cancer WP2446,0.7506345650267451,0.8633301425036574,0.24763446129098945,"['RB1', 'CDKN1B', 'PRMT2', 'H2AFZ', 'HDAC1', 'FAF1', 'HMGB2', 'CDC7', 'POLA1', 'ANLN', 'CDK6', 'CCND1', 'CCNE2', 'TFDP2', 'RPA3', 'STMN1', 'ABL1', 'MCM4', 'MCM6', 'SKP2']",0.9998978587529065,0,0,20
410,B Cell Receptor Signaling Pathway WP23,0.7531332163294515,0.8663130694954441,0.24561114956961713,"['GSK3B', 'KLF11', 'MEF2C', 'CD81', 'GAB1', 'BRAF', 'GAB2', 'CBL', 'ILF2', 'FOXO1', 'NFKB1', 'CDC42', 'MAPK8', 'CREB1', 'BLNK', 'MAPK1', 'FYN', 'RAC1', 'SOS1', 'MAP3K7', 'HRAS', 'MEF2D']",0.9998978587529065,0,0,22
411,Phosphodiesterases in neuronal function WP4222,0.7597157422596564,0.8338423414372782,0.2291489968354197,"['GUCY1A2', 'GUCY1A1', 'PDE4D', 'ADCY8', 'GRIN2B', 'ADCY5', 'GRIN2A', 'CREB1', 'ADCY9', 'PDE10A', 'ADORA2A', 'DRD1', 'PDE7A']",0.9998978587529065,0,0,13
412,Autosomal recessive Osteopetrosis pathways WP4788,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['OSTM1', 'NFKB1']",0.9998978587529065,0,0,2
413,Bile acids synthesis and enterohepatic circulation  WP4389,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['ABCG8', 'MAPK1']",0.9998978587529065,0,0,2
414,Canonical NF-KB pathway WP4562,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['NFKBIE', 'NFKB1']",0.9998978587529065,0,0,2
415,HIF1A and PPARG regulation of glycolysis WP2456,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['LDHA', 'PPARG']",0.9998978587529065,0,0,2
416,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['STAT1', 'BLVRB']",0.9998978587529065,0,0,2
417,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['TGFB1', 'IFNGR2']",0.9998978587529065,0,0,2
418,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['TGFB1', 'NFKB1']",0.9998978587529065,0,0,2
419,Valproic acid pathway WP3871,0.7603389314538652,0.7486555997194295,0.2051248834516374,"['HDAC1', 'HSD17B10']",0.9998978587529065,0,0,2
420,ATM Signaling Pathway WP2516,0.7647974048894025,0.8082716627634661,0.2167334476592917,"['PIDD1', 'MRE11', 'CREB1', 'CRADD', 'GADD45A', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.9998978587529065,0,0,9
421,Genes targeted by miRNAs in adipocytes WP1992,0.7660920143740662,0.7485968194574368,0.19946586328337484,"['TMSB4X', 'PTBP2', 'KCNJ2']",0.9998978587529065,0,0,3
422,IL1 and megakaryocytes in obesity WP2865,0.7660920143740662,0.7485968194574368,0.19946586328337484,"['PIK3CA', 'TIMP2', 'NFKB1']",0.9998978587529065,0,0,3
423,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7660920143740662,0.7485968194574368,0.19946586328337484,"['TGFB1', 'TLR4', 'NFKB1']",0.9998978587529065,0,0,3
424,NO metabolism in cystic fibrosis WP4947,0.7660920143740662,0.7485968194574368,0.19946586328337484,"['PRMT5', 'PRMT2', 'DDAH1']",0.9998978587529065,0,0,3
425,Overview of nanoparticle effects WP3287,0.7660920143740662,0.7485968194574368,0.19946586328337484,"['AKT3', 'BAX', 'PTK2']",0.9998978587529065,0,0,3
426,Codeine and Morphine Metabolism WP1604,0.7707872180595162,0.7487143525011688,0.19492248472429896,['ABCB1'],0.9998978587529065,0,0,1
427,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.7707872180595162,0.7487143525011688,0.19492248472429896,['GSS'],0.9998978587529065,0,0,1
428,Hypothetical Craniofacial Development Pathway WP3655,0.7707872180595162,0.7487143525011688,0.19492248472429896,['ARHGAP29'],0.9998978587529065,0,0,1
429,Nucleotide GPCRs WP80,0.7707872180595162,0.7487143525011688,0.19492248472429896,['ADORA2A'],0.9998978587529065,0,0,1
430,"Phase I biotransformations, non P450 WP136",0.7707872180595162,0.7487143525011688,0.19492248472429896,['CES2'],0.9998978587529065,0,0,1
431,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7719778650219528,0.7858614232209737,0.2033804660856522,"['SMAD2', 'TGFB1', 'PIK3CA', 'MAPK1', 'BAX', 'BRAF', 'MAP3K5']",0.9998978587529065,0,0,7
432,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7747326073530012,0.8163282698084666,0.2083574495675268,"['MAP2K3', 'MAPK10', 'MAP2K4', 'MAPK8', 'MAP3K1', 'MKNK1', 'MAPK1', 'TAB2', 'IL1RAP', 'MAP3K7', 'NFKB1', 'NFKBIB']",0.9998978587529065,0,0,12
433,BMP Signaling Pathway in Eyelid Development WP3927,0.7755400638193288,0.7485380116959064,0.19027509578816298,"['SFRP1', 'MAP3K1', 'EGFR', 'FGFR2']",0.9998978587529065,0,0,4
434,Glycosaminoglycan degradation WP4815,0.7755400638193288,0.7485380116959064,0.19027509578816298,"['HPSE2', 'IDUA', 'GLB1', 'ARSB']",0.9998978587529065,0,0,4
435,miRNA targets in ECM and membrane receptors WP2911,0.7755400638193288,0.7485380116959064,0.19027509578816298,"['COL4A2', 'LAMB2', 'SDC2', 'LAMC1']",0.9998978587529065,0,0,4
436,Small cell lung cancer WP4658,0.7770520976008481,0.8549269766661071,0.215653518430109,"['RB1', 'LAMA5', 'CDKN1B', 'LAMB2', 'GADD45A', 'PIK3R3', 'LAMC1', 'PIK3CB', 'FHIT', 'PTK2', 'NFKB1', 'CKS1B', 'CDK6', 'CCND1', 'CCNE2', 'PIK3CA', 'COL4A2', 'TRAF3', 'AKT3', 'RARB', 'CYCS', 'BAX', 'SKP1', 'NFKBIB']",0.9998978587529065,0,0,24
437,Vitamin D Receptor Pathway WP2877,0.7770520976008481,0.8549269766661071,0.215653518430109,"['CDKN2D', 'ABCB1', 'TGFB1', 'CDKN1B', 'GADD45A', 'IGFBP3', 'TPM1', 'CDKAL1', 'EFNA5', 'TRAK1', 'RASGRP1', 'CYP3A5', 'SLC8A1', 'FOXO1', 'SFRP1', 'CEACAM1', 'CCND1', 'ADGRE5', 'PNOC', 'CREG2', 'TIMP2', 'SPP1', 'CLPTM1L', 'CD200']",0.9998978587529065,0,0,24
438,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.785865769782897,0.7484791764155359,0.18036048636053792,"['RB1', 'MBD3', 'CBX5', 'H3F3B', 'HDAC1']",0.9998978587529065,0,0,5
439,Monoamine Transport WP727,0.785865769782897,0.7484791764155359,0.18036048636053792,"['PPP2CB', 'ADORA2A', 'AMPH', 'SLC6A1', 'NECTIN2']",0.9998978587529065,0,0,5
440,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.785865769782897,0.7484791764155359,0.18036048636053792,"['RB1', 'PRKAA1', 'GOT1', 'MDH2', 'SCO2']",0.9998978587529065,0,0,5
441,Striated Muscle Contraction Pathway WP383,0.785865769782897,0.7484791764155359,0.18036048636053792,"['TMOD1', 'MYOM1', 'TPM3', 'TPM1', 'ACTG1']",0.9998978587529065,0,0,5
442,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7959153071796886,0.8244399848651031,0.1881887294185149,"['SMAD2', 'GSK3B', 'TGFB1', 'DCC', 'GADD45A', 'BRAF', 'BBC3', 'MAPK10', 'MAPK8', 'TBK1', 'CCND1', 'APC', 'AKT3', 'MAPK1', 'CYCS', 'BAX', 'RAC1', 'EXOC2']",0.9998978587529065,0,0,18
443,Wnt signaling WP428,0.7970154511922867,0.8414806110458284,0.1909161423301704,"['WNT10B', 'GSK3B', 'CAMK2D', 'ROCK2', 'PRICKLE2', 'PRKCA', 'PRICKLE1', 'NKD1', 'LRP6', 'PPP3CA', 'SFRP1', 'MAPK8', 'CCND2', 'FRAT2', 'PPP3R2', 'PPP3CC', 'PLCB4', 'CCND1', 'APC', 'CSNK2B', 'ROR1', 'RAC1', 'PLCB1', 'MAP3K7']",0.9998978587529065,0,0,24
444,Autophagy WP4923,0.8061325303446825,0.7483614232209738,0.16127721525039845,"['RPTOR', 'PRKAA1', 'MAP1LC3B', 'ATG9A', 'PRKAG1', 'AMBRA1', 'WIPI2']",0.9998978587529065,0,0,7
445,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8073190059758076,0.8117505516339347,0.17374415782688415,"['IDI1', 'PRKAA1', 'SEC24B', 'CYP51A1', 'PRKAG1', 'ACACA', 'ACLY', 'CDK8', 'RBP4', 'CREB1', 'PIK3CA', 'PPARG', 'PRKACA', 'SEC24D', 'ATF6', 'SEC23B', 'KPNB1']",0.9998978587529065,0,0,17
446,Fatty acid transporters WP5061,0.8146513415722829,0.673666978484565,0.1380984020185464,"['FABP5', 'FABP6', 'ACSL4']",0.9998978587529065,0,0,3
447,Major receptors targeted by epinephrine and norepinephrine WP4589,0.8146513415722829,0.673666978484565,0.1380984020185464,"['ADCY9', 'ADCY8', 'ADCY5']",0.9998978587529065,0,0,3
448,NOTCH1 regulation of endothelial cell calcification WP3413,0.8146513415722829,0.673666978484565,0.1380984020185464,"['LPAR1', 'SOX6', 'DLL3']",0.9998978587529065,0,0,3
449,Omega-3/Omega-6 FA synthesis WP4723,0.8146513415722829,0.673666978484565,0.1380984020185464,"['ACOX1', 'ACOT2', 'ACSL4']",0.9998978587529065,0,0,3
450,Tryptophan catabolism leading to NAD+ production WP4210,0.8146513415722829,0.673666978484565,0.1380984020185464,"['HAAO', 'QPRT', 'KMO']",0.9998978587529065,0,0,3
451,Nicotine Activity on Dopaminergic Neurons WP1602,0.8175918069070554,0.6908861898335582,0.13913900715180222,"['CHRNB2', 'CHRNA4', 'GNB1', 'PRKACA']",0.9998978587529065,0,0,4
452,15q11.2 copy number variation syndrome WP4940,0.8180080798652773,0.6416379972610976,0.12889420740905852,"['CYFIP1', 'TUBGCP4']",0.9998978587529065,0,0,2
453,Cytokines and Inflammatory Response WP530,0.8180080798652773,0.6416379972610976,0.12889420740905852,"['TGFB1', 'HLA-DRA']",0.9998978587529065,0,0,2
454,Cytosine methylation WP3585,0.8180080798652773,0.6416379972610976,0.12889420740905852,"['MBD3', 'TET2']",0.9998978587529065,0,0,2
455,EDA signaling in hair follicle development WP3930,0.8180080798652773,0.6416379972610976,0.12889420740905852,"['BMP1', 'LTB']",0.9998978587529065,0,0,2
456,Estrogen Receptor Pathway WP2881,0.8180080798652773,0.6416379972610976,0.12889420740905852,"['ACOX1', 'PPARA']",0.9998978587529065,0,0,2
457,Heart Development WP1591,0.8229978332208255,0.701626111371081,0.13667796704053262,"['MEF2C', 'BMP2', 'BMPR2', 'MAPK1', 'BMPR1A']",0.9998978587529065,0,0,5
458,Ferroptosis WP4313,0.8246218708801197,0.7482435597189696,0.1442840570631438,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'GSS', 'LPCAT3', 'VDAC2', 'SLC3A2', 'SAT2', 'ACSL4']",0.9998978587529065,0,0,9
459,PPAR signaling pathway WP3942,0.8264567943003239,0.7695202383742341,0.14667643548077966,"['ACADL', 'FABP5', 'ACOX1', 'FABP6', 'ME1', 'ILK', 'APOA1', 'ACSL4', 'PPARG', 'PPARA', 'CPT1B', 'SLC27A5']",0.9998978587529065,0,0,12
460,AMP-activated protein kinase (AMPK) signaling WP1403,0.8310048628177618,0.7828384746280379,0.14491877063414496,"['PRKAA1', 'STRADB', 'INSR', 'PRKAG1', 'PIK3R3', 'PIK3CB', 'ADIPOR1', 'CPT1B', 'ACACB', 'ACACA', 'RPTOR', 'PIK3CA', 'RPS6KB1', 'LEPR', 'PLCB1']",0.9998978587529065,0,0,15
461,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8310048628177618,0.7828384746280379,0.14491877063414496,"['RYR2', 'ATP2A2', 'CACNA2D2', 'CACNA1C', 'SLC8A1', 'ACTG1', 'CACNB2', 'CACNG7', 'SGCD', 'CACNB4', 'CDH2', 'ITGA10', 'ITGA8', 'CACNG2', 'EMD']",0.9998978587529065,0,0,15
462,NRF2 pathway WP2884,0.841114187725991,0.8127900083808589,0.14063530935453702,"['HSP90AB1', 'MGST3', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'SLC39A6', 'ME1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'HSP90AA1', 'TGFB1', 'SLC2A13', 'SLC39A11', 'SLC39A12', 'CES4A', 'SLC6A6', 'SLC6A9', 'MAFF', 'BLVRB', 'SQSTM1', 'EPHA3', 'CES2']",0.9998978587529065,0,0,25
463,IL-4 signaling pathway WP395,0.8411379772160714,0.7481255857544518,0.1294254040347589,"['STAT5B', 'PIK3CA', 'RPS6KB1', 'STAT1', 'EP300', 'MAPK1', 'GAB2', 'JAK2', 'SOS1', 'CBL', 'NFKB1']",0.9998978587529065,0,0,11
464,Acetylcholine Synthesis WP528,0.8414141598718676,0.5614773258532024,0.0969510079987438,['PDHA1'],0.9998978587529065,0,0,1
465,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.8414141598718676,0.5614773258532024,0.0969510079987438,['COX8A'],0.9998978587529065,0,0,1
466,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.8414141598718676,0.5614773258532024,0.0969510079987438,['ACOT2'],0.9998978587529065,0,0,1
467,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.8414141598718676,0.5614773258532024,0.0969510079987438,['ABCB1'],0.9998978587529065,0,0,1
468,SARS-CoV-2 and COVID-19 Pathway WP4846,0.8414141598718676,0.5614773258532024,0.0969510079987438,['CTSL'],0.9998978587529065,0,0,1
469,Osteoblast differentiation WP4787,0.8418016855017315,0.8062294407894737,0.1388414334197541,"['WNT10B', 'BMPR2', 'STAT1', 'PRKCE', 'WNT8A', 'PIK3R3', 'PRKCA', 'PIK3CB', 'FGF1', 'RUNX2', 'GLI3', 'LRP6', 'DLL3', 'MAPK10', 'BMP2', 'MAPK8', 'PIK3CA', 'MAPK1', 'PPARG', 'PRKD1', 'MAPK6', 'FGFR2', 'BMPR1A']",0.9998978587529065,0,0,23
470,Wnt signaling pathway and pluripotency WP399,0.8429737952889588,0.7985486939838071,0.13640761399154913,"['MAP2K4', 'WNT10B', 'GSK3B', 'CREBBP', 'PRKCE', 'PRKCA', 'PPP2R5C', 'NKD1', 'LRP6', 'SOX2', 'MAPK10', 'PPP2CB', 'CCND2', 'CCND1', 'APC', 'PPP2R5E', 'PPP2R2B', 'EP300', 'PRKD1', 'MAP3K7', 'PAFAH1B1']",0.9998978587529065,0,0,21
471,Phosphoinositides metabolism WP4971,0.8430480565590786,0.7182954811519551,0.12263553278160975,"['PLCB4', 'PIK3CA', 'PIP4K2A', 'PLCE1', 'PIK3CB', 'PLCH2', 'PLCB1', 'SBF2']",0.9998978587529065,0,0,8
472,Differentiation of white and brown adipocyte WP2895,0.8543575042740794,0.6123607449613062,0.09638897956516426,"['BMP2', 'PPARG', 'PPARGC1A']",0.9998978587529065,0,0,3
473,GDNF/RET signaling axis WP4830,0.8543575042740794,0.6123607449613062,0.09638897956516426,"['SOX11', 'SLIT2', 'GLI3']",0.9998978587529065,0,0,3
474,Hypertrophy Model WP516,0.8543575042740794,0.6123607449613062,0.09638897956516426,"['ZEB1', 'WDR1', 'ADAM10']",0.9998978587529065,0,0,3
475,IL-9 signaling pathway WP22,0.8543575042740794,0.6123607449613062,0.09638897956516426,"['STAT5B', 'STAT1', 'MAPK1']",0.9998978587529065,0,0,3
476,Serotonin and anxiety WP3947,0.8543575042740794,0.6123607449613062,0.09638897956516426,"['PPP3CA', 'CRH', 'GRM1']",0.9998978587529065,0,0,3
477,1q21.1 copy number variation syndrome WP4905,0.8547324341423355,0.6602851716259738,0.10364285149817662,"['TJP1', 'AFDN', 'PRKAA1', 'PRKAG1', 'TJP2']",0.9998978587529065,0,0,5
478,7-oxo-C and 7beta-HC pathways WP5064,0.8547324341423355,0.6602851716259738,0.10364285149817662,"['HSD11B1', 'DBP', 'ACOT2', 'ACOT6', 'SLC27A5']",0.9998978587529065,0,0,5
479,ATM Signaling Network in Development and Disease  WP3878,0.856319462201765,0.7239740363762761,0.11229689346109495,"['PRKAA1', 'MRE11', 'DCLRE1C', 'KAT5', 'ATMIN', 'ATM', 'PPM1D', 'NFKB1', 'HMGN1', 'MAP3K5']",0.9998978587529065,0,0,10
480,"GPCRs, Other WP117",0.856319462201765,0.7239740363762761,0.11229689346109495,"['GPR176', 'ADGRV1', 'ADORA2A', 'GRM8', 'CELSR2', 'GRM1', 'CELSR3', 'ADGRL2', 'GPR135', 'ADGRL3']",0.9998978587529065,0,0,10
481,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8628972023508862,0.5613747954173486,0.08278016544335641,"['MAPK8', 'MAFF']",0.9998978587529065,0,0,2
482,Iron metabolism in placenta WP2007,0.8628972023508862,0.5613747954173486,0.08278016544335641,"['TFR2', 'MCOLN1']",0.9998978587529065,0,0,2
483,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8628972023508862,0.5613747954173486,0.08278016544335641,"['IDI1', 'PMVK']",0.9998978587529065,0,0,2
484,Transcriptional cascade regulating adipogenesis WP4211,0.8628972023508862,0.5613747954173486,0.08278016544335641,"['DDIT3', 'PPARG']",0.9998978587529065,0,0,2
485,IL-5 signaling pathway WP127,0.8671251357769238,0.6905966896601409,0.09845973790543527,"['GSK3B', 'STAT5B', 'RPS6KB1', 'STAT1', 'RPS6', 'MAPK1', 'JAK2', 'SOS1']",0.9998978587529065,0,0,8
486,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8768825302112437,0.701276645584446,0.09213529698328231,"['RB1', 'MAP2K3', 'MAP2K4', 'HSP90AA1', 'MAPK8', 'CCND1', 'BAX', 'CFLAR', 'EGFR', 'MAP3K5']",0.9998978587529065,0,0,10
487,16p11.2 distal deletion syndrome WP4950,0.8815662735243379,0.6235376696303229,0.07860010161512643,"['CD81', 'INSR', 'ATP2A1', 'JAK2', 'SDCCAG8']",0.9998978587529065,0,0,5
488,DNA Mismatch Repair WP531,0.8815662735243379,0.6235376696303229,0.07860010161512643,"['POLE4', 'POLD4', 'RPA3', 'POLD2', 'POLE3']",0.9998978587529065,0,0,5
489,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8815662735243379,0.6235376696303229,0.07860010161512643,"['TICAM2', 'PIK3CA', 'CBLB', 'TLR4', 'NFKB1']",0.9998978587529065,0,0,5
490,Ovarian infertility WP34,0.8822511735610643,0.5986432748538012,0.0749971232693934,"['CDKN1B', 'CCND2', 'NCOR1', 'ATM']",0.9998978587529065,0,0,4
491,Statin inhibition of cholesterol production WP430,0.8822511735610643,0.5986432748538012,0.0749971232693934,"['ABCA1', 'ABCG8', 'APOA1', 'APOE']",0.9998978587529065,0,0,4
492,Triacylglyceride synthesis WP325,0.8822511735610643,0.5986432748538012,0.0749971232693934,"['DGAT2', 'AGPAT1', 'PLPP1', 'AGPAT4']",0.9998978587529065,0,0,4
493,Spinal Cord Injury WP2431,0.8827855447719093,0.76034399735754,0.09479435123749086,"['RB1', 'EPHA4', 'TGFB1', 'CDKN1B', 'GADD45A', 'ROCK2', 'OMG', 'PRKCA', 'EGFR', 'RHOB', 'CDC42', 'PPP3CA', 'CCND1', 'PRB1', 'APEX1', 'MAPK1', 'RAC1', 'LTB', 'SLIT2', 'TLR4']",0.9998978587529065,0,0,20
494,Neovascularisation processes WP4331,0.8827947539248423,0.6413025308414965,0.07994640699368225,"['SMAD2', 'MAPK8', 'TGFB1', 'ANGPT1', 'MAPK1', 'NFKB1']",0.9998978587529065,0,0,6
495,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8827947539248423,0.6413025308414965,0.07994640699368225,"['LATS1', 'RAP1A', 'YWHAQ', 'RAC1', 'TEAD1', 'FOXO1']",0.9998978587529065,0,0,6
496,Vitamin A and carotenoid metabolism WP716,0.8851252075069467,0.6546114232209738,0.07987972257003599,"['SULT1A1', 'ABCG8', 'RBP4', 'CRABP2', 'CRABP1', 'MAPK1', 'RARB']",0.9998978587529065,0,0,7
497,ESC Pluripotency Pathways WP3931,0.8856910046205481,0.7698876388733027,0.09345446049468811,"['MAP2K3', 'WNT10B', 'GSK3B', 'ACTR2', 'BMPR2', 'GAB1', 'LIFR', 'BRAF', 'FGF1', 'EGFR', 'LRP6', 'FGF14', 'APC', 'AKT3', 'SELENOP', 'MAPK1', 'IL6ST', 'SOS1', 'MAPK6', 'FGF12', 'HRAS', 'FGFR2', 'BMPR1A']",0.9998978587529065,0,0,23
498,Cholesterol Biosynthesis Pathway WP197,0.8864073028398811,0.5612722170252572,0.06767748789129223,"['IDI1', 'CYP51A1', 'PMVK']",0.9998978587529065,0,0,3
499,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8864073028398811,0.5612722170252572,0.06767748789129223,"['TRPA1', 'ACOX1', 'PPARA']",0.9998978587529065,0,0,3
500,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8864073028398811,0.5612722170252572,0.06767748789129223,"['EED', 'STK38', 'JARID2']",0.9998978587529065,0,0,3
501,PPAR-alpha pathway WP2878,0.8864073028398811,0.5612722170252572,0.06767748789129223,"['CCND1', 'APOA1', 'PPARA']",0.9998978587529065,0,0,3
502,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8864073028398811,0.5612722170252572,0.06767748789129223,"['ACLY', 'PDHA1', 'PC']",0.9998978587529065,0,0,3
503,Netrin-UNC5B signaling pathway WP4747,0.8880994107199507,0.6649496605010536,0.07891063564060286,"['ARHGEF12', 'PIK3CA', 'MAPK1', 'PRKCA', 'FYN', 'RAC1', 'NEO1', 'PTK2']",0.9998978587529065,0,0,8
504,Benzo(a)pyrene metabolism WP696,0.8902823024572881,0.4491351098644226,0.05219698809668593,['AKR1A1'],0.9998978587529065,0,0,1
505,Biogenic Amine Synthesis WP550,0.8902823024572881,0.4491351098644226,0.05219698809668593,['GAD1'],0.9998978587529065,0,0,1
506,Drug Induction of Bile Acid Pathway WP2289,0.8902823024572881,0.4491351098644226,0.05219698809668593,['ABCB1'],0.9998978587529065,0,0,1
507,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.8902823024572881,0.4491351098644226,0.05219698809668593,['CREB1'],0.9998978587529065,0,0,1
508,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.8902823024572881,0.4491351098644226,0.05219698809668593,['HIF1AN'],0.9998978587529065,0,0,1
509,PTF1A related regulatory pathway WP4147,0.8902823024572881,0.4491351098644226,0.05219698809668593,['KAT2B'],0.9998978587529065,0,0,1
510,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.8902823024572881,0.4491351098644226,0.05219698809668593,['NFKB1'],0.9998978587529065,0,0,1
511,Small Ligand GPCRs WP247,0.8902823024572881,0.4491351098644226,0.05219698809668593,['LPAR1'],0.9998978587529065,0,0,1
512,Ganglio Sphingolipid Metabolism WP1423,0.8974059860354406,0.4989478606499883,0.05400956668212088,"['ST8SIA1', 'ST3GAL5']",0.9998978587529065,0,0,2
513,Glutathione metabolism WP100,0.8974059860354406,0.4989478606499883,0.05400956668212088,"['GPX4', 'GSS']",0.9998978587529065,0,0,2
514,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8974059860354406,0.4989478606499883,0.05400956668212088,"['STAG1', 'ANAPC11']",0.9998978587529065,0,0,2
515,DNA Repair Pathways Full Network WP4946,0.8974783054418141,0.782071841801354,0.0845938418011129,"['FEN1', 'MRE11', 'DCLRE1C', 'MPG', 'CETN2', 'POLD4', 'BRIP1', 'RAP1A', 'POLD2', 'REV3L', 'USP1', 'XRCC6', 'CENPX', 'XRCC5', 'REV1', 'FANCC', 'RAD23A', 'FANCB', 'GTF2H3', 'GTF2H5', 'FANCF', 'DDB1', 'POLE4', 'NEIL2', 'RPA3', 'APEX1', 'POLE3', 'ATM', 'ERCC5', 'MNAT1']",0.9998978587529065,0,0,30
516,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9037025799955792,0.6120885900899943,0.06197701620545638,"['NDUFA13', 'HSP90AA1', 'COPS6', 'ERBIN', 'RAC1', 'AAMP']",0.9998978587529065,0,0,6
517,T-cell receptor (TCR) signaling pathway WP69,0.9040075925837053,0.7177668308702791,0.07243524832985203,"['VAV3', 'CD83', 'TGFB1', 'ITPR1', 'CBLB', 'GAB2', 'CBL', 'NFKB1', 'CDC42', 'MAPK8', 'CREB1', 'MAPK1', 'FYN', 'SOS1', 'MAP3K7', 'HRAS']",0.9998978587529065,0,0,16
518,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9040383218610362,0.5906583257394774,0.05958769577226334,"['BMP2', 'RBL1', 'THRA', 'STAT1', 'MAPK1']",0.9998978587529065,0,0,5
519,Oxidative Stress WP408,0.9040383218610362,0.5906583257394774,0.05958769577226334,"['MAPK10', 'TXNRD2', 'NFKB1', 'TXN2', 'SOD1']",0.9998978587529065,0,0,5
520,Notch Signaling WP268,0.9062358061930601,0.6411345619961869,0.06312337457864294,"['KAT2B', 'CREBBP', 'HDAC1', 'PSEN2', 'NUMB', 'MAML3', 'DTX4', 'DLL3']",0.9998978587529065,0,0,8
521,Urea cycle and associated pathways WP4595,0.9063474573668424,0.5611695906432749,0.055181230899835294,"['GOT1', 'MDH2', 'PYCR1', 'SLC25A12']",0.9998978587529065,0,0,4
522,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9108240648583044,0.6598872859052265,0.06163711737131126,"['GSK3B', 'DLG1', 'PIK3CA', 'FYN', 'SOS1', 'CBL', 'CALM1', 'MAP3K7', 'NFKB1', 'PDK1']",0.9998978587529065,0,0,10
523,Dopaminergic Neurogenesis WP2855,0.9236686849519948,0.4490063128361001,0.03565192638253557,"['SOX2', 'TGFB1']",0.9998978587529065,0,0,2
524,ID signaling pathway WP53,0.9236686849519948,0.4490063128361001,0.03565192638253557,"['RB1', 'RBL1']",0.9998978587529065,0,0,2
525,Biomarkers for urea cycle disorders WP4583,0.9240940165059753,0.3742402992052361,0.029543076751994163,['GOT1'],0.9998978587529065,0,0,1
526,Caloric restriction and aging WP4191,0.9240940165059753,0.3742402992052361,0.029543076751994163,['PPARGC1A'],0.9998978587529065,0,0,1
527,"Cerebral organic acidurias, including diseases WP4519",0.9240940165059753,0.3742402992052361,0.029543076751994163,['MDH2'],0.9998978587529065,0,0,1
528,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.9240940165059753,0.3742402992052361,0.029543076751994163,['CYP51A1'],0.9998978587529065,0,0,1
529,Disorders of Folate Metabolism and Transport WP4259,0.9240940165059753,0.3742402992052361,0.029543076751994163,['SLC46A1'],0.9998978587529065,0,0,1
530,Glial Cell Differentiation WP2276,0.9240940165059753,0.3742402992052361,0.029543076751994163,['TPPP'],0.9998978587529065,0,0,1
531,Glucuronidation WP698,0.9240940165059753,0.3742402992052361,0.029543076751994163,['PGM5'],0.9998978587529065,0,0,1
532,Liver X receptor pathway WP2874,0.9240940165059753,0.3742402992052361,0.029543076751994163,['ABCG8'],0.9998978587529065,0,0,1
533,Mevalonate pathway WP3963,0.9240940165059753,0.3742402992052361,0.029543076751994163,['PMVK'],0.9998978587529065,0,0,1
534,Role of Osx and miRNAs in tooth development WP3971,0.9240940165059753,0.3742402992052361,0.029543076751994163,['RUNX2'],0.9998978587529065,0,0,1
535,Serine Metabolism WP4688,0.9240940165059753,0.3742402992052361,0.029543076751994163,['PSPH'],0.9998978587529065,0,0,1
536,Serotonin Transporter Activity WP1455,0.9240940165059753,0.3742402992052361,0.029543076751994163,['PPP2CB'],0.9998978587529065,0,0,1
537,Supression of HMGB1 mediated inflammation by THBD WP4479,0.9240940165059753,0.3742402992052361,0.029543076751994163,['NFKB1'],0.9998978587529065,0,0,1
538,Type III interferon signaling WP2113,0.9240940165059753,0.3742402992052361,0.029543076751994163,['STAT1'],0.9998978587529065,0,0,1
539,Gastric Cancer Network 1 WP2361,0.9259590674938942,0.5281045751633987,0.040624575880839536,"['APC', 'MCM4', 'CEP192', 'GATD3B']",0.9998978587529065,0,0,4
540,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9259590674938942,0.5281045751633987,0.040624575880839536,"['BMP2', 'OMG', 'SOX6', 'SOX5']",0.9998978587529065,0,0,4
541,Breast cancer pathway WP4262,0.9302237437897235,0.7470588235294118,0.054034867090716567,"['RB1', 'GSK3B', 'MRE11', 'PIK3R3', 'FGF1', 'EGFR', 'IGF1R', 'LRP6', 'DLL3', 'FRAT2', 'CCND1', 'AKT3', 'MAPK1', 'HRAS', 'SKP1', 'NCOA1', 'WNT10B', 'GADD45A', 'NCOA3', 'BRAF', 'CDK6', 'PIK3CA', 'RPS6KB1', 'APC', 'CSNK2B', 'BAX', 'ATM', 'SOS1', 'SOS2']",0.9998978587529065,0,0,29
542,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9322205020894125,0.48099024455432315,0.03375873419365593,"['GSK3B', 'BAX', 'BCL2L2']",0.9998978587529065,0,0,3
543,One-carbon metabolism and related pathways WP3940,0.9350958738546553,0.5982673846874268,0.04014746038340191,"['GPX4', 'CHDH', 'GAD1', 'GSS', 'DNMT3A', 'BCAT1', 'CDO1', 'SOD1']",0.9998978587529065,0,0,8
544,Bladder cancer WP2828,0.9351590295190237,0.5816947565543071,0.03899604812414116,"['RB1', 'CCND1', 'DAPK2', 'MAPK1', 'BRAF', 'HRAS', 'EGFR']",0.9998978587529065,0,0,7
545,Modulators of TCR signaling and T cell activation WP5072,0.9365032729396637,0.6230967439681424,0.040876555999065284,"['GNA13', 'FIBP', 'CDKN1B', 'NDUFB10', 'RASA2', 'CBLB', 'ELOB', 'RNF7', 'MEF2D', 'NFKB1']",0.9998978587529065,0,0,10
546,Tryptophan metabolism WP465,0.9380562547007475,0.5342937362123137,0.0341656046376806,"['ECHS1', 'WARS', 'HAAO', 'HSD17B10', 'CYP2C18']",0.9998978587529065,0,0,5
547,Nanoparticle triggered autophagic cell death WP2509,0.9417871435182243,0.49871345029239766,0.02991083402171742,"['MAP1LC3A', 'INSR', 'ATG10', 'AMBRA1']",0.9998978587529065,0,0,4
548,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9417871435182243,0.49871345029239766,0.02991083402171742,"['GSK3B', 'CCND1', 'APC', 'LRP6']",0.9998978587529065,0,0,4
549,Matrix Metalloproteinases WP129,0.943489927801962,0.40814504644291877,0.023741629843202827,"['MMP16', 'TIMP2']",0.9998978587529065,0,0,2
550,Omega-9 FA synthesis WP4724,0.943489927801962,0.40814504644291877,0.023741629843202827,"['ACOT2', 'ACSL4']",0.9998978587529065,0,0,2
551,Metapathway biotransformation Phase I and II WP702,0.9465877391446917,0.7077246582967407,0.03884814884200555,"['NAA50', 'CHST7', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSS', 'CYP51A1', 'AKR1A1', 'HNMT', 'HS6ST1', 'CYP2C18', 'NAT14', 'CYP3A5', 'HS6ST2', 'HS6ST3', 'HS2ST1', 'SULT1A1', 'GSTZ1', 'AKR7A2', 'CYP2U1', 'CYP4V2', 'NDST3', 'SULT4A1']",0.9998978587529065,0,0,24
552,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9474319100279951,0.6167525773195877,0.03330476707438236,"['LATS1', 'UPF1', 'MRE11', 'DCLRE1C', 'KAT5', 'ABL1', 'NABP2', 'BAX', 'ATM', 'MCPH1', 'RAD9A']",0.9998978587529065,0,0,11
553,ATR Signaling WP3875,0.9474874749068266,0.3207440058772457,0.0173014324253274,['RAD9A'],0.9998978587529065,0,0,1
554,Blood Clotting Cascade WP272,0.9474874749068266,0.3207440058772457,0.0173014324253274,['KLKB1'],0.9998978587529065,0,0,1
555,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.9474874749068266,0.3207440058772457,0.0173014324253274,['CCND1'],0.9998978587529065,0,0,1
556,Mitochondrial CII Assembly WP4920,0.9474874749068266,0.3207440058772457,0.0173014324253274,['SDHAF1'],0.9998978587529065,0,0,1
557,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9480804050201623,0.4488774555659495,0.02393233466608608,"['MAP1LC3A', 'ATG10', 'WIPI1']",0.9998978587529065,0,0,3
558,Glucocorticoid Receptor Pathway WP2880,0.9555011718981709,0.5901788906560146,0.02686452338289281,"['TGFBR3', 'EPB41L4B', 'FGD4', 'RGS2', 'HSP90AA1', 'NAV3', 'ABHD2', 'PLK2', 'PTGES3', 'NR3C1']",0.9998978587529065,0,0,10
559,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9567451031952806,0.5414648714968359,0.02394264142913359,"['MAPK8', 'TGFB1', 'CCND1', 'COL4A2', 'RAC1', 'SOS1', 'NFKB1']",0.9998978587529065,0,0,7
560,Prostaglandin Synthesis and Regulation WP98,0.958319466379455,0.5177050892005257,0.022040820155928356,"['HSD11B1', 'SCGB1A1', 'ANXA6', 'MITF', 'PPARG', 'PPARGC1A']",0.9998978587529065,0,0,6
561,Mammalian disorder of sexual development WP4842,0.9583452432573893,0.3740939911152677,0.015916646901726884,"['EMX2', 'FGFR2']",0.9998978587529065,0,0,2
562,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9604233139638371,0.42077876520112256,0.016991526085810508,"['BAX', 'FADD', 'BBC3']",0.9998978587529065,0,0,3
563,Kallmann's Syndrome WP5074,0.9604233139638371,0.42077876520112256,0.016991526085810508,"['PIK3CA', 'MAPK1', 'GNRH1']",0.9998978587529065,0,0,3
564,Monoamine GPCRs WP58,0.9645504648592255,0.4487485380116959,0.016196737392036347,"['CHRM1', 'DRD1', 'HTR4', 'HTR5A']",0.9998978587529065,0,0,4
565,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9648531268968422,0.6226547842401501,0.02227820794579565,"['GSK3B', 'WNT10B', 'NKD1', 'LRP6', 'CDK8', 'SFRP1', 'CCND2', 'FRAT2', 'CDK6', 'HNRNPK', 'CCND1', 'APC', 'CSNK2B', 'ROR1', 'MAP3K7']",0.9998978587529065,0,0,15
566,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9704581321450012,0.5276626220612337,0.015823028441934395,"['ABCA1', 'IDI1', 'ELOVL4', 'PMVK', 'CYP51A1', 'ACOT2', 'ACSL4', 'TM7SF2']",0.9998978587529065,0,0,8
567,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9704581321450012,0.5276626220612337,0.015823028441934395,"['RPTOR', 'PRKAA1', 'MAP1LC3A', 'ATG10', 'WIPI1', 'WIPI2', 'GTPBP2', 'ACACA']",0.9998978587529065,0,0,8
568,Allograft Rejection WP2328,0.971625835386844,0.506425939350006,0.014577213222022213,"['ABCB1', 'TGFB1', 'STAT1', 'HLA-B', 'HLA-DRA', 'HLA-A', 'HLA-F']",0.9998978587529065,0,0,7
569,Wnt signaling in kidney disease WP4150,0.972523193101286,0.42733500417710946,0.011906132181196297,"['MAPK10', 'WNT10B', 'MAPK8', 'LRP6']",0.9998978587529065,0,0,4
570,Neural Crest Differentiation WP2064,0.9742205773999918,0.5827754336615096,0.01522065806317912,"['GSK3B', 'HDAC1', 'HDAC11', 'WNT8A', 'MITF', 'NFKB1', 'RHOB', 'DLL3', 'CDH2', 'MPZ', 'TCF4', 'FGFR2', 'SOX5']",0.9998978587529065,0,0,13
571,Glycerolipids and Glycerophospholipids WP4722,0.977300472971472,0.3739476145930776,0.008586258924363394,"['DGAT2', 'CDIPT', 'AGPAT4']",0.9998978587529065,0,0,3
572,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9776153918074653,0.32058518988610174,0.007257710867901327,"['ACADL', 'ACSL4']",0.9998978587529065,0,0,2
573,Oxysterols derived from cholesterol WP4545,0.9787898526027508,0.40786815523657627,0.008744005847210587,"['DBP', 'ACOT2', 'ACOT6', 'SLC27A5']",0.9998978587529065,0,0,4
574,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9826156410108668,0.22445067788686301,0.003936245718361985,['ADAR'],0.9998978587529065,0,0,1
575,Fluoropyrimidine Activity WP1601,0.982907777622424,0.3542292353896903,0.006106905113224174,"['DPYD', 'GGH', 'CES2']",0.9998978587529065,0,0,3
576,Peptide GPCRs WP24,0.9875022105312735,0.3738011695906433,0.00470112674322814,"['OPRD1', 'ATP8A1', 'NPY1R', 'NMBR']",0.9998978587529065,0,0,4
577,TYROBP causal network in microglia WP3945,0.9875022105312735,0.3738011695906433,0.00470112674322814,"['APBB1IP', 'DPYD', 'SPP1', 'ZFP36L2']",0.9998978587529065,0,0,4
578,Purinergic signaling WP4900,0.9881163417334552,0.2804535889642273,0.0033527759257331526,"['ADORA2A', 'GNAI3']",0.9998978587529065,0,0,2
579,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9881163417334552,0.2804535889642273,0.0033527759257331526,"['MDH2', 'IDH3B']",0.9998978587529065,0,0,2
580,Ethanol effects on histone modifications WP3996,0.9904060020916197,0.3204262996124549,0.0030890110393013773,"['KAT2B', 'AHCY', 'HDAC1']",0.9998978587529065,0,0,3
581,Lung fibrosis WP3624,0.9904554760771147,0.35881169590643275,0.0034411350621362012,"['TGFB1', 'FAM13A', 'SPP1', 'FGF1']",0.9998978587529065,0,0,4
582,DNA IR-damage and cellular response via ATR WP4016,0.9912228210295617,0.5314920420450255,0.004685594137381552,"['SMARCAL1', 'UPF1', 'FEN1', 'MRE11', 'POLN', 'XRCC5', 'PPM1D', 'BRIP1', 'HERC2', 'UIMC1', 'USP1', 'ATM', 'MCPH1', 'RAD9A']",0.9998978587529065,0,0,14
583,NAD+ biosynthetic pathways WP3645,0.9913742772379806,0.2639288121140437,0.002286452151458873,"['TNKS', 'QPRT']",0.9998978587529065,0,0,2
584,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.9913742772379806,0.2639288121140437,0.002286452151458873,"['MAPK8', 'KEAP1']",0.9998978587529065,0,0,2
585,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9920049646490056,0.4928865979381443,0.003956483045190728,"['GSK3B', 'WNT10B', 'SFRP1', 'FRAT2', 'CCND2', 'CCND1', 'APC', 'CSNK2B', 'ROR1', 'NKD1', 'LRP6']",0.9998978587529065,0,0,11
586,Kennedy pathway from sphingolipids WP3933,0.9942455368519763,0.17260042435358003,0.0009960915238984834,['SGPL1'],0.9998978587529065,0,0,1
587,Glycerophospholipid Biosynthetic Pathway WP2533,0.9946776760915769,0.2925021352747387,0.0015609487398421632,"['PIK3CA', 'PIK3CB', 'CDIPT']",0.9998978587529065,0,0,3
588,Fatty acid beta-oxidation WP143,0.9958245193030495,0.3202673350041771,0.0013400697438927234,"['ECHS1', 'ACADL', 'ACSL4', 'CPT1B']",0.9998978587529065,0,0,4
589,Eicosanoid Synthesis WP167,0.9960192455254717,0.16025512589327456,0.0006392094231333955,['PTGES2'],0.9998978587529065,0,0,1
590,Differentiation Pathway WP2848,0.9970769496527169,0.2690458372310571,0.000787586166559277,"['ALK', 'TGFB1', 'FGF1']",0.9998978587529065,0,0,3
591,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9986815578282333,0.13193355883727964,0.00017406153810924522,['ACOX1'],0.9998978587529065,0,0,1
592,Complement and Coagulation Cascades WP558,0.9991301970267519,0.18681318681318682,0.00016256137376856138,"['CLTC', 'KLKB1']",0.9998978587529065,0,0,2
593,"GPCRs, Class A Rhodopsin-like WP455",0.9998046628437528,0.39277885480417124,7.67317990611989e-05,"['OPRD1', 'RABGAP1', 'CHRM1', 'OPN3', 'GPR22', 'NPY1R', 'RRH', 'NMBR', 'HTR4', 'HTR5A', 'ADORA2A', 'PRLHR', 'DRD1']",0.9998978587529065,0,0,13
594,Hematopoietic Stem Cell Differentiation WP2849,0.9998978587529065,0.09338475923328658,9.538922934651112e-06,['ZNF835'],0.9998978587529065,0,0,1
